Tor Paaske Utheim

Bilde av Tor Paaske Utheim
English version of this page
Telefon +47 22840318
Brukernavn
Besøksadresse E-mail for fast replies: utheim2@gmail.com
Postadresse Postboks 1052 Blindern 0316 OSLO

 CURRICULUM VITAE – TOR PAASKE UTHEIM

Citizenship/Date of birth:                    

Norwegian/March 9, 1976
Home address:   Bygdøylund 11, 0286 Oslo
Telephone/E-mail address:   (+47) 46846963 /   utheim2@gmail.com

              Table of Contents

Summary

Academic Background and Main Positions

Supervisor Experience

Awards/Honors

Publicity Based on Innovation/Research From the Research Group

Television

Newspapers

Web Pages

Funding

Administrative Qualifications

Teaching and Pedagogic Qualifications

Patent Applications

Establishment of Companies

Board Member of Companies

International Collaboration

Invited Talks

Various Scholarly Achievements in Chronological Order

Publications

References

 

Summary

  • Awards/honors: 21 (5 related to innovation)
  • Ongoing (20) og completed (13) supervision of PhD candidates as main supervior or co-supervisor: 33 
  • Ongoing (12) og completed (9) supervision of medical or dentist research students (3-years research programmes) as main- or co-supervior: 21
  • Publications in peer-reviewed journals: >140, including 10 first or sole authorships. As of May 22, 2020, 22 papers (five in press), including three papers in Ocular Surface (impact factor 9.1).
  • Publications in Nature group journals: Nature Communications (x 1), Scientific Reports (x 12), and Scientific Data (x 1): 14
  • Publications in the highest ranked journal in ophthalmology for original research (impact factor 9,1): 4 (3 so far this year)
  • Scientific abstracts: >180
  • National (94) and international (51) invited talks: 145
  • Patent applications: 6
  • Companies established: 7
  • Current positions related to research and/or innovation: 15
  • Main academic achievements: 

Seven professorships (5 x 5% and 2 x 20%), Harvard Medical School faculty member (since 2013); together with my research group, recipient of the largest innovation prize related to health care in Norway (Medinnova’s Innovation Award of $33,000 based on stem cell research); winner of the European Society of Ophthalmology Award for most promising Norwegian Young Clinician/Researcher; received the Oslo University Hospital Early Career Award for outstanding research ($20,000); received a Norwegian Research Council grant in 2017 of $1.3 million (principal investigator; obtained an European commision grant of $5 million (consortium member) in 2017 as well an European commission COST action (consortium member) in 2018.

 

Academic Background and Main Positions

2019–present  Professor, Department of Computer Sciences, Oslo Metropolitan University, Oslo, Norway
2019–present  Professor, Department of Product Design, Oslo Metropolitan University, Oslo, Norway
2019–present  Professor, Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
2018–present Professor of Innovation, Department of Research and Development, Oslo Metropolitan University, Oslo, Norway
2018–present President, Oslo Society of Ophthalmology (established 1905), Oslo, Norway
2018–present Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2017–present  Professor, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway
2017–present  Director of Innovation/Senior Consultant/Senior Scientist, Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway
2017–present Director of Research/Director of Innovation/Senior Consultant, Department of Ophthalmology, Sørlandet Hospital Arendal, Norway
2017–present Senior Scientist, Department of Maxillofacial Surgery, Oslo University Hospital, Oslo, Norway
2017–2019     Senior Consultant, Mobilize Strategy Consulting, Copenhagen, Denmark
2016–present  Professor and Head of Electron Microscopy Lab, Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway
2016–present  Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2016–present  Senior Scientist, Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2016–present  Senior Consultant/Senior Scientist, Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
2016–present  Editor-in-Chief, Oftalmolog (a Nordic journal of ophthalmology)
2015–present    Professor, Department of Optometry and Visual Science/National Centre for Optics, Vision and Eye Care, Faculty of Health Sciences, University of South Eastern Norway, Kongsberg, Norway
2015–present    Director of Research/Senior Consultant, Department of Ophthalmology, Drammen Hospital, Drammen, Norway
2015–2019   Director of Research, Norwegian Dry Eye Clinic, Oslo/Fredrikstad/Tromsø, Norway
2014–present   Head, Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital 
2013–present   Adjunct Clinical Associate, Schepens Eye Research Institute/Massachusetts Eye and Ear,Department of Ophthalmology, Harvard Medical School, Boston, MA (appointed Faculty Member in December 2013)
2015–2017       Vice President, Norwegian Society of Ophthalmology
2015–2016  Director of Innovation, Oslo University Hospital (1-year engagement)
2014–2015   Associate Professor/Group Leader, Institute of Oral Biology, Faculty of Dentistry, University of Oslo
2014   Visiting Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School (2 months)
2013–2014 Acting Group Leader, Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital
2012–2013     Fulbright Visiting Scholar, Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School
2012–2013 Director of Research, Dry Eye Clinic, Oslo, Norway
2012–2013   Chief Executive Officer, SynsLaser in Oslo and Tromsø, Norway
2011  Ophthalmologist (completed the 5-year training program at the Department of Ophthalmology, Oslo University Hospital)
2011 Senior Research Fellow, Department of Medical Biochemistry, Oslo University Hospital 
2010 Doctor of Philosophy (PhD), “Novel technology in regenerative medicine: Eye bank storage of limbal explant cultures for transplantation”, Faculty of Medicine, University of Oslo, Oslo, Norway
2010 Chief Scientific Officer, Regena Medical AS, Oslo, Norway 
2009 Director of Research, Ophthalmology, Inven2, Oslo University Hospital
  Guest Scientist, Kyoto Prefectural University of Medicine, Kyoto, Japan
2008 Visiting Scientist, Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, US
2007–2011 Resident of Ophthalmology, Department of Ophthalmology, Oslo University Hospital, Oslo, Norway (with a few short leaves of absence due to research or innovation projects, the longest being 6 months as a consequence of an invitation to Harvard Medical School in 2008)
2005–2007  Lecturer/PhD student, Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
2004–2005 Resident of Ophthalmology Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
2003–2004 Lecturer, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2001  Doctor of Medicine (MD) (laudabilis), Faculty of Medicine, University of Oslo, Oslo, Norway   

                           

Supervisor Experience

 

PhD supervisor experience - current or past: 33

  • Ongoing supervision of 20 PhD students, all as co-supervisor, except two. Of note, enrollment of 7 students is pending and several of the PhD students have previously been medical research students. Srinath Murali, Yue Feng (application submitted; enrollment pending), Wen Zhou, Per Jensen, Morten Gundersen (application submitted, enrollment pending), Christian Nilsen, Pål Galteland, Sam Enayati, Behzod Tashbayev, Reza Badian, Panagiotis Salvanos, Vilde Thomseth, Amela Tulek, Nora Botten (application submitted, enrollment pending), Yasin Adil (application submitted; enrollment pending), Jiaxin Xiao (application submitted, enrollment pending), Ayyad Khan (application submitted; enrollment pending), Markus Olsen (application submitted; enrollment pending), Håvard Hynne, Julie Frigaard
  • Completed supervision as main supervisor: 9 PhD students. Jon Roger Eidet, Catherine Jackson, Rakibul Islam, Xiangjun Chen, Aleksandar Stojanovic, Lara Pasovic, Øygunn Aass Utheim, Erlend Sommer Landsend, and Marit Lippestad
  • Completed supervision as co-supervisor: 4 PhD candidates. Ida Fostad, Peder Aabel, Minou Nivani and Sherimin Rusthen (dissertation in October 19, 2020).  

Research student supervisor experience - current or past: 19 

  • Ongoing supervision as 12 medical or dentist students at the University of Oslo (three years research commitments - most of the students are aiming for PhD); project leader for all, but five. Haakon Fjærvoll, Ketil Fjærvoll, Victoria Lyngstaadass, Marie Wangen, Jonatan Olafsson, Sara Tellefsen, Inger Thea Myklebust, Mohammed Bayar Korkosh, Hamida Achour, Morten Magnø, Anna Zajkowska, Aurora McQueen.
  • Completed supervision of 9 medical research students at the University of Oslo (three years research commitments - most of the students are aiming for PhD); project leader for all, but two: Lara Pasovic (2015) Marlen Parissi (2016), Marit Lippestad (2017), Nora Botten (2018), Yasin Adil (2018), Jiaxin Xiao (2018), Ayyad Khan (2018), Haakon Ringstad (2019), Markus Vicente Olsen (2019). The first medical student (Lara Pasovic) got 8 publications and 2 patent applications and defended her medical research thesis on November 25, 2015 and her PhD thesis during internship

Postdoctoral fellow supervisor experience - current or past: 6

  • Ongoing supervision of 4 postdoctoral fellows. Catherine Jackson, Mazyar Yazdini, Anton Lenninov, Karen Chang.
  • Completed supervision of 2 postdoctoral fellows. Jon Roger Eidet, Rok Kosmina

Medical student supervisor experience - current or past: 11

  • Completed supervision of 11 medical students (three months mandatory research projects at the Faculty of Medicine, University of Oslo. A digital publication at the University of Oslo is the aim of this research program. The studies are formally listed as master’s theses by the University of Oslo), main supervisor for all, but three: Anders Kvalheim (2008), Hedvig Eidahl (2009), Simen Birkenes (2009), Aje Singh Dhillon (2009), Faiza Abbas (2013), Mohammad Ismail Saaeed (2013), Nora Borgersen (2017), Isabel Espelid (2018), Jonatan Olafsson (2019), Hamida Achour (2020), Solveig Skjeggedal Bjornes (2020).

Master student`s experience - current or past: 1

  • Co-supervisor: master’s studentMaria Aukrust Naqvi, Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway

Informal supervision: 5 

  • Scientists volunteering over a prolonged time in the research group: 5

Leila Rad (about 1.5 years), Hamed Sadeghiankaffash (about one year), Samer Marshan (about one year), Mads Istre (one year), Mathias Kaurstad (about one year)

 

Awards/Honors

 

  • 2017: Short Term Scientific Mission Scholarship, European Cooperation in Science and Technology under the Seventh Framework Programme (FP7)
  • 2017: Oslo University Hospital Early Career Award for Outstanding ResearchPrize money, NOK 150,000.Evaluation criteria: 1) Maximum 8 years of experience since PhD completion and scientific track record showing great promise (any age); and 2) scientific excellence, i.e., peer review evaluation of scientific quality and impact. The international evaluation committee was led by Professor Sten Lindahl, Karolinska institute. Professor Lindahl has previously served as chairman for the Nobel Prize Committee for Physiology/Medicine.
  • 2016: Innovator of the Month, South-Eastern Norway Regional Health Authority, January 2016
  • 2015: Søren Holth Award (includes prize money) for best presentation skills evaluated over the past 2 years, Norwegian Society of Ophthalmology (the first time the award was given since 2005)
  • 2015: Outstanding Reviewer Award (Nanomedicine: Nanotechnology, Biology, and Medicine, Elsevier 5-year Impact Factor: 7.3)
  • 2015: Scholarship for the European Leadership Development Programme (2015–2017) 
  • 2014: Travel Award by Oslo University Hospital to Harvard Medical School
  • 2014: Scholarship to attend a course, equivalent to one-third of a master’s degree, on innovation in collaboration with the Norwegian Business School; University of California, Berkeley, CA; and Stanford University, CA (selected by the Norwegian Research Council based on an ongoing innovation project in competition with innovation projects from a variety of disciplines, including IT, agriculture, oil industry, and medicine). Three were selected from Oslo University Hospital for the scholarship, two of whom were from my research group.
  • 2014: Best Poster Award (2nd European Conference on Aniridia, Venice, Italy)
  • 2013: Alcon Research Prize in Ophthalmology
  • 2013: Travel Award by Oslo University Hospital to Harvard Medical School
  • 2013: Lecturer Travel Award (sponsored in part by the US Department of State)
  • 2012: Fulbright Visiting Scholarship to Harvard University (14 months), sponsored in part by the US Department of State
  • 2012: Most Promising Young Clinician/Researcher Award resulting in the European Society of Ophthalmology (SOE) Lecturer Award, National Society of Ophthalmology, November 2012
  • 2012: Travel Award by Oslo University Hospital to Harvard Medical School
  • 2010: DNB Innovation Prize (finalist in Oslo)
  • 2009: Director’s Award for Excellent Research, Oslo University Hospital, Ullevål, Norway
  • 2008: Best Poster Award, Nordic Congress of Ophthalmology
  • 2008: First prize winner of the Medinnova Innovation Competition, the largest innovation prize in health care in Norway (prize money: NOK 250,000; shared with members of the research group)
  • 2007: Second prize winner of the Medinnova Innovation Competition
  • 2001: The Voluntary International Medical Exam first prize winner among University of Oslo students. The award and prize money were received at a ceremony at University Aula, Oslo, Norway, November 21, 2001 
  • 1995: Best all-time overall graduating score from high school. The score resulted in press releases in some of the largest newspapers in Norway. The school was founded in 1951. 

Awards/Honors Based on Co-Author Contribution

  • 2019: Best Paper Award, Oslo University Hospital. Six research groups were awarded for their excellent papers published during the second half-year of 2018 on June 7th 2019 in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. Co-author contribution in: «Lång E, Polec A, Lång A, Blicher P, Rowe AD, Tønseth KA, Jackson C, Utheim TP, Eriksson JE, Bøe SO: Coordinated Collective Migration and Oriented Nuclear Partitioning in Sheets of Cultured Human Keratinocytes, Nature Communications, Nat Commun. 2018 Sep 10;9(1):3665”
  • 2018: 14th International Sjogren’s Syndrome Symposium Travel Award (co-author contribution)
  • 2017: International Colour Vision Society Travel Award (co-author contribution)
  • 2017: Best paper, Department of Medical Biochemistry, Oslo University Hospital (August–December 2017), resulting in nomination to the twice-yearly best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the entire hospital (last author contribution)
  • 2016: Best thesis, Department of Oral Biology, Faculty of Dentistry, from January 2014 to January 2016, resulting in nomination for The Kings Gold Medal, University of Oslo, Norway. PhD candidate: Rakibul Isla; main supervisor: Tor Paaske Utheim; thesis title: Treatment of Limbal Stem Cell Deficiency: Cell-Based Regenerative Therapy and Storage System (main supervisor contribution)
  • 2016: Best paper (PMID: 26940175), Department of Medical Biochemistry, Oslo University Hospital (January–July 2016), resulting in nomination to the best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the hospital (last author contribution)
  • 2015: European League Against Rheumatism (EULAR) Conference, Zürich, Switzerland: Poster Selected for “Guided Poster Tour” (co-author contribution)
  • 2014: Association for Research in Vision and Ophthalmology (ARVO) International Travel Grant (last author contribution)

      (last author contribution)

  • 2010: ARVO International Travel Grant (co-author contribution)
  • 2008: Director’s Award for Excellent Research, Oslo University Hospital (second author contribution)

 

Publicity Based on Innovation/Research From the Research Group

 

Television

  • EuroNews, Science/Hi-Tec, week 38, 2007 (the main European news channel).
  • NRK Dagsrevyen, August 16, 2007 (the main Norwegian news channel)
  • Schrødingers Katt, September 2, 2010 (the main Norwegian science channel)

Newspapers

  • Dagens næringsliv, August 11, 2017
  • Optikeren (nr 1. 2016)
  • Klassekampen (February 26, 2016)
  • Alt om syn (Norwegian journal about vision), October 28, 2011 and issue nr 4, 2015
  • Nationen (Norwegian newspaper), September 5, 2015
  • The Journal of the Norwegian Medical Association, August 12, 2010
  • Aftenposten (main Norwegian newspaper) November 22, 2007 
  • Ullevål-Nytt (newspaper for Oslo University Hospital, Ullevål), December, 2007

Web Pages

  • tidsskriftet.no, forskning.no (x3), forskningsradet.no (x2), EuroNews.com (main page), nrk.no, helse-sorost.no, oslo-universitetssykehus.no, tannlegeforeningen.no, medinnova.no, blindeforbundet.no, abcnyheter.no, optikeren.no, dn.no, innovationmanagement.se, sciencedaily.comntbinfo.nomedicaldaily.comhealthcanal.comodont.uio.nouio.no (main page for 10 days), MedicalXpress.com, scifeeds.com, scincenordic.com, dental-tribune.com, etc

 

Funding

  • Total funding based on grant applications as either project leader or project collaborator over the past 12 years has increased steadily and about half of which was secured over the past 4 years. The funding includes an EU grant (Horizon 2020) of $5 million (consortium member) and a Norwegian Research Council grant of $1.3 million (principal investigator)

 

Administrative Qualifications

 

2018- present President of the Oslo Society of Ophthalmology (established 1905), Oslo, Norway
2018–present   Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2017- present   Director of Innovation/Senior Consultant/Senior Scientist, Stavanger University Hospital, Stavanger, Norway
2017- present   Director of Research/Director of Innovation/Senior Consultant Department of Ophthalmology, Sørlandets Sykehus, Arendal, Norway
2016- present  

Editor-in-Chief for Oftalmolog a Nordic Journal of Ophthalmology

  Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Norway
2015 –present  Director of Research, Department of Ophthalmology, Drammen Hospital, Norway
2015 –2017  Vice President, The Norwegian Society of Ophthalmology, Oslo, Norway 
2015 - 2016 Director of Innovation, Oslo University Hospital, Norway 
2013 - present  Acting Group Leader and later (2014) Group Leader of the Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital
2014 - present  Head of the electron microscopy laboratory, Institute of Oral Biology, Faculty of Dentistry, University of Oslo (since autumn 2015 shared position with Professor Linda Hildegard Bergersen)  
2014 - present     Head of the Scientific Committee of Aniridia Europe
2011 - present  Head of the Scientific Committee of Aniridia Norway
2012 - 2013 Director of Research, the Dry Eye Clinic, Oslo and Tromsø, Norway 
2012 - 2013 Chief Executive Officer of SynsLaser (private eye clinic with its own unit for research and development) in Oslo and Tromsø, Norway 
2010   Chief Scientific Officer of Regena Medical AS, Norway
2009  Director of Research for Ophthalmology, Medinnova (now Inven2, owned by Oslo University Hospital and the University of Oslo)
2008 Shared Project Leader (with Professor Darlene A. Dartt) on a project related to storage of cultured cells at Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US

            

 

Teaching and Pedagogic Qualifications

 

  • Co-authored a book with Sten Ræder, Utheim TP, and Utheim OA entitled: Ophthalmology – basal clinical examination (Unipub, Oslo, Norway, 2012, 133 pages), which has been distributed to thousands of medical students in Norway and abroad since 2008. The authors are in the final stages of writing a more comprehensive book on ophthalmology
  • Teaching responsibilities in ophthalmology to more than 650 medical students since 2004. None of them failed their oral examination

 

Patent Applications

 

  • United Kingdom Patent Application No. WO/2008/131973: Transplant storage I. Submitted by Inven2 April 26, 2007
  • United Kingdom Patent Application No. WO/2008/131973: Transplant storage II. Submitted by Inven2 April 4, 2008. 
  • United Kingdom Patent Application No. 1020436.0: Instant transplatation of cells Submitted by Stavanger University Hospital. Submitted by Inven2 December 2, 2010.
  • United Kingdom Patent Application. A novel storage method for cultured retinal pigment epithelial cells for transplantation. Submitted by Inven2 Februar 28, 2014.
  • United Kingdom Patent Application. A novel storage method for mammalian cells, tissue and organs. Submitted by Inven2 Februar 28, 2014.
  • United Kingdom Patent Application No. 1511482.0: Growth medium retinal pigment epithelial (RPE)-cells.Submitted by Inven2 Juni 30, 2015.

 

Establishment of Companies

  • 2020 – Hera Graphics (software company) – received NOK 700.000 immediately upon establishment 
  • 2017 - Velotrail (bike safety company)
  • 2016 - The Eye Health Clinic
  • 2016 - The Glaucoma Clinic
  • 2015 - Digital Ophthalmology 
  • 2012 – The Norwegian Dry Eye Clinic
  • 2010 - Regena Medical (a biotech company) – received NOK 5.000.000 immediately upon establishement

 

Board Member of Companies

  • The Eye Health Clinic (Chair)
  • The Glaucoma Clinic (Chair)
  • Research and Innovation Invest (Chair)
  • Oslo Society of Ophthlamology (Chair)
  • Hera Graphics (Member)

International Collaboration

Number of scientists in my group previously or currently performing research at Department of Ophthalmology, Harvard Medical School: about 40

Invited Talks

  • MSD Ophthalmology National Meeting, Oslo, Norway, 2006
  • XXXVII Nordic Congress of Ophthalmology, Copenhagen, Denmark, 2006
  • The Norwegian Society of Ophthalmology, Oslo, Norway, 2006
  • Pfizer`s Supplementary Training Meeting, Oslo, Norway, 2007
  • Oslo University Innovation talk at the “Opening of the Idea Polyclinic, Ullevål” with press coverage, August 17, 2007
  • Invited Speaker, Oslo Ophthalmology Society, Oslo, Norway, 2007
  • Oslo and Akershus University College, Norway, 2007
  • Inven2 Innovation prize talk, Rikshospitalet, Oslo University Hospital Norway (the main auditorium with press coverage), November 21, 2008
  • Cornea Innovation, Soria Moria, Oslo, Norway, September 2, 2008
  • Cambridge Innovation Center, Cambridge, MA, October 16, 2008
  • Inven2 Innovation prize talk with status after one year, Rikshospitalet, Oslo University Hospital Norway, November 20, 2009
  • Kyoto Prefectural University of Medicine, Japan, December 2009
  • El Centro de Oftalmologia Barraquer, Barcelona, Spain, August, 2009
  • Transplant Services Foundation, Hospital Clínic i Provincial de Barcelona, Spain, August, 2009
  • Invited Speaker, BMI (Biomedical innovation AS), Oslo, Norway, August 25, 2009
  • Invited Speaker, NeoMed, Oslo, November, Norway, 2009
  • DnB Nor, Oslo, Norway, November 2009
  • DLA Piper, Oslo, Norway, November 2009
  • Invited Speaker, Sigma fondsforvaltning AS, Oslo, Norway, September 10, 2009
  • Oslo University Hospital, Ulleval, Oslo, Norway, October 17, 2009
  • Southern and Eastern Norway Regional Health Authority Board Meeting (talk on innovation), Drammen, Norway December 10, 2009
  • The Norwegian Stem Cell Meeting, Losby, Lørenskog, Norway, October 19, 2010
  • The 2nd Asia Cornea Society Biennial Scientific Meeting, Kyoto, Japan, December 2, 2010
  • SOE Lecturer, The Norwegian Society of Ophthalmologists, Soria Moria, Norway, November 2, 2012
  • Harvard Cornea Center of Excellence Scientific Retreat, The American Academy of Arts and Sciences, US, December 15, 2012
  • Thea Laboratories (invited talk for the administration) Seattle, Washington, US, May 6, 2014
  • Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US, May 30, 2013
  • Wayne State University, Detroit, US, June 24, 2013 
  • The Royal Society of Medicine, London, UK, October 19, 2013
  • Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway, February 28, 2014
  • Newcastle University, Newcastle, UK, June 3, 2014 
  • The German Ophthalmological Society, Leipzig, September 27, Germany, 2014
  • 2nd European Conference on Aniridia, September 19, Italy, 2014
  • COST Training School, Nottingham, September, UK, 2014
  • Kongsberg Vision Meeting, October 27, 2014
  • Oslo Vest Rotery Club, October 29, 2014
  • BI Norwegian Business School, Oslo, Norway, September 3, 2014
  • University of California, Berkeley (BI Innovation project), CA, US, October 17, 2014 
  • Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 16, 2015
  • Aniridia Norway, Hurdal, Akershus, Oslo, May 30 2015
  • Oslo University Hospital Research Seminar (October 19, 2015) 
  • Sundvolden Conference Center, Hønefoss, Norway (October 27, 2015)
  • Oslo Conference Center, Oslo, Norway (November 12, 2015)
  • Oslo University Hospital Seminar (December 7, 2015) 
  • Innovation at Oslo University Hospital: “Brukerutvalget” Oslo University Hospital, March 25, 2016
  • The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Board of Directors, Oslo University Hospital, April 28, 2016
  • Testbeds in the health sector, Innovation network for the Southern Eastern Norway Regional Health Authority, Oslo, Norway, April 13
  • The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Conference for Health and Medical Technology, Drammen, April 14, 2016
  • Innovation – the sky is the limit, Telemark Hosptial Trust, Farris bad, Larvik, Norway, May 31, 2016
  • Innovation in dentistry, Faculty of Dentistry, Quality Hotel Leangkollen, Asker, Norway, June 1, 2016
  • Innovation – Oslo Tech, Oslo Science Park, Oslo, Norway, June 2, 2016
  • Innovation in ocular stem cell therapy, Department of Ophthalmology, Drammen Hospital, June 2, 2016
  • The use of oral mucosal cells for treating corneal blindness - how can it be possible and what other  options are there in 2016? The Harvard seminar, Faculty of Dentistry, University of Oslo, June 8, 2016
  • The rationale for the establishment of test beds for Oslo University Hospital and Oslo Municipality, Oslo University Hospital, Aker, June 15, 2016
  • Nordic Congress of Ophthalmology, Aarhus, Denmark 8-12 June
  • Innovation strategy for medical students, University of Oslo, August 15, 2016
  • The rationale for a testbed for Oslo University Hospital and the Municipality of Oslo, European telemedicine conference, Oslo Spectrum, Norway, August 16, 2016
  • Innovation in the health sector from an economic perspective, Oslo University Hospital (two-days seminar for economics at the hospital), August 25, 2016
  • 3rd Scientific European Aniridia Conference 27-28th August 2016, Duisburg, Germany
  • Innovation seminar, Faculty of Dentistry, University of Oslo (both speaker and moderator), January 18, 2017
  • Limbal stem cell deficiency, Charles University, Prague, Czech Republic, January 19, 2017
  • Innovation in the future, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital (two-days seminar, Norefjell, Norway, March 3, 2017
  • Stem cells and innovation – What is possible in 2017? - Agder Eye Seminar [Agder Øyelegeforum], Lillesand, Norway, March 7, 2017
  • Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 20, 2017
  • Stem cell therapy, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, March 31, 2017
  • Treatment of corneal blindness - Norwegian Institute for air research, Kjeller, Norway, April 6, 2017
  • Innovation – opportunities and pitfalls, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, June 2, 2017
  • Innovation, Novartis Nordic Meeting, Tallinn, August 23, 2017
  • Dry eye disease – an update, Novartis Nordic Meeting, Tallinn, August 23, 2017
  • Stem cell in ophthalmology, Novartis Nordic Meeting, Tallinn, August 23, 2017
  • Dry eye disease – upcoming treatment strategies, Novartis Nordic Meeting, Talinn, August 24, 2017
  • Innovation at Oslo University Hospital, Monrad Krohn Auditorium, Oslo, Norway, October 11, 2017
  • Innovation at the Univeristy of Oslo, Faculty of Dentistry, Oslo, Norway, November 1, 2017
  • Opportunities in Innovation, Oslo University Hospital, Monrad Krohn Auditorium, November 3, 2017
  • Ophthalmology for general practitioners, Novartis, Grand Hotel, Oslo, Norway, November 17, 2017 
  • Innovation in research, OsloMet (three-hours seminar for research leaders at the university), Pilestredet 46, 0167 Oslo, Norway, January 24, 2018
  • Innovation, OsloMet (invited talk at a one-day seminar for the entire administration, including Rector, at OsloMet), Bristol hotel, Kristian IVs gate 7, 0164 Oslo, Norway, January 31, 2018
  • Innovation, Stavanger University Hospital, February 6, 2018
  • Innovation - what, why and how, Clinic of Neurology, Oslo University Hospital, February 28, 2018
  • Innovation, OsloMetropolitan University, March 7, 2018
  • Experiences from the Norwegian Dry Eye Clinic, Norvartis Nordic Advisory Board, Stockholm, March 21, 2018
  • Dry Eye Disease/The Norwegian Dry Eye Clinic, Novartis Ophthlamic Days, Nyborg, Denmark, April 14, 2018, 
  • Research driven innovation, Kosmopol, Copenhagen, Denmark, April 15, 2018
  • Innovation and ophthalmology, Boston University, April 26, 2018
  • Future innovation at Stavanger University Hospital, Stavanger University Hospital (invited by the CEO of the hospital), May 22, 2018
  • Management of dry eye disease, Shire, Stockholm, May 30, 2018
  • Innovation inspirational seminar (IT - students about 200 participants), Oslo Metropolitan University, Oslo, August 14, 2018
  • Dry eye disease – an update, Thea Laboratoies and Iogen, Helsinki, Finland, August 17, 2018
  • Innovation - why, when, how, Thea Laboratoies and Iogen, Stockholm, Sweden, August 18, 2018
  • Dry eye disease - unmet needs, Elsemay Björn symposium, Tampere, Finland, August 20
  • Stem cells: possibilities for therapy in 2018 – Nordic Congress of Ophthalmology, Oslo, August 22, 2018
  • Is it possible to do research in private practise? – Nordic Congress of Ophthalmology, Oslo, August 24, 2018
  • Innovation inspirational seminar, Oslo Metropolitan University (students with various background - about 300 participants), Oslo, August 27, 2018
  • Innovation – what, why and how; Resarch group leadership seminar, Division of Laboratory Medicine and Division of Radiology and Nuclear Medicine, Oslo, September 19, 2018
  • Swedish Ophthalmology Society, Thea Symposium on dry eye disease, Stockholm, Sweden, October 8, 2018
  • Swedish Ophthalmology Society, Santen Symposium on dry eye disease, Stockholm, Sweden, October 9, 2018 (moderator with brief, introductory talk on dry eye disease) 
  • Dry Eye Disease, University Hospital of North Norway (ophthalmology residents, 70 participants), Oslo, October 23, 2018
  • Innovation inspirational seminar, Oslo Metropolitan University (physiotherapists and nurses - about 120 participants), Oslo, October 26, 2018
  • Innovation Seminar, Division for Head, Neck and Reconstructive Surgery, presenter, moderator and organizer, Oslo, November 6, 2018
  • Ophthalmology for general practitioners, Novartis, Radison SAS, Holberg plass, Oslo, Norway, November 1, 2017 
  • Innovation – Myths and Facts, Monrad Krohn Auditorium, Oslo, Norway, November 6, 2017
  • Innovation and artificial intelligence; Symposium on Artificial Intelligence, AIM 2 North 2018 - Explore the possibilities and impact around Artificial Intelligence, connecting Man and Machine; Main Auditorium, Oslo Metropolitan University, Oslo, November 7, 2018
  • Innovation, Faculty of Technology, Art and Design, OsloMet, (Keynote Speaker), Scandic hotel, St. Olavs plass 1, 0165 Oslo, November 22, 2018
  • Innovation, Department of Medical Biochemistry, Oslo University Hospital, Quality hotel Leangkollen, Bleikeråsen 215, 1387 Asker, November 30, 2018
  • Innovation, Department of Reseach and Development, Oslo Metropolitan University, Pilestredet 46, Oslo, December 12, 2018
  • Innovation, Department of Life Sciences and Health, Oslo Metropolitan University (OsloMet), Oslo Metropolitan University, Pilestredet 46, Oslo, January 25, 2019
  • Innovation, Biotek 2021 research programme, The Norwegian Research Council/Mobilize Consulting Strategy, Kringler hotel, 2032 Maura, Akershus, Norway, January 18, 2019
  • Dry eye disease, Department of ophthalmology, Stavanger University Hospital, Stavanger, Norway, February 14, 2019
  • Innovation, Department of Medical Biochemistry, Oslo University Hospital, Norway, March 4, 2019
  • Innovation, Research group leadership programme, University of Stavanger, Mobilize Consulting Strategy, March 5, 2019
  • Innovation – myths and facts; Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital (two-days seminar, Sundvolden Hotel, Dronningveien 2, 3531 Krokkleiva, March 7, 2019)
  • Dry eye disease – Specsavers/the Norwegian Dry Eye Clinic, Specsavers Norway AS, Grenseveien 107 B, 0663 Oslo, March 12, 2019
  • Dry eye disease and innovation, Department of Ophthalmology, Sørlandet Hospital Trust, Arendal, Norway, March 15, 2019
  • Dry eye disease and innovation, Department of Ophthalmology, Norrköping Hospital, arranged by Thea, March 21, 2019
  • Dry eye disease and innovation, SPÖK (Stockholms privata ögonläkar klubb), arrangded by Santen, Freys hotel, Stockholm, April 4, 2019
  • Ophthalmology – key concepts, The Norwegian Society of the Blind and Partially Sighted, April 8, 2019
  • Dry eye disease, Department of Ophthalmology, Sørlandet Hospital, Arendal, May 24, 2019
  • The potential of innovation, Metropolitan University, Oslo, Norway, May 27, 2019
  • Innovation, NMBU, Mobilize Strategy Consulting, Refsnes Gods, Moss, Norway, May 28, 2019
  • Inspirational talk – innovation, Innovation camp bachelor institutt IT, Oslo Metropolitan University, Oslo, Norway, August 14, 2019
  • Inspirational talk – innovation, Innovation camp, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway, August 26, 2019
  • Innovation, The fifth animal models of neuroregenerative diseases, Conference Center, Chateau Liblice, Czech republic, September 15 – September 18, 2019; September 17, 2019
  • Ocular surface disease - unmet clinical needs; perspectives from Norway; European TFOS Ambassador Meeting, September 21st, in Rome, Italy
  • KEY NOTE SPEAKER - Dry eye disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 6th October – Utrecht, The Netherlands – early session for employees except opticians/optometrists
  • KEY NOTE SPEAKER - Dry Eye Disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 6th October – Utrecht, The Netherlands – late session for opticians/optometrists
  • KEY NOTE SPEAKER - Dry eye disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 8th October – Oslo, Norway – early session for employees except opticians/optometrists
  • KEY NOTE SPEAKER - Dry Eye Disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 8Th October – Oslo, Norway– late session for opticians/optometrists
  • KEY NOTE SPEAKER - Dry eye disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 10th October – Stockholm, Sweden – early session for employees except opticians/optometrists
  • KEY NOTE SPEAKER - Dry Eye Disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 10th October – Stockholm, Sweden – late session for opticians/optometrists
  • KEY NOTE SPEAKER - Dry eye disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 10th October – Stockholm, Sweden – early session for employees except opticians/optometrists
  • KEY NOTE SPEAKER - Dry Eye Disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 10th October – Stockholm, Sweden – late session for opticians/optometrists
  • KEY NOTE SPEAKER - Dry eye disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 11th October – Helsinki, Finland – early session for employees except opticians/optometrists
  • KEY NOTE SPEAKER - Dry Eye Disease – the most underdiagnosed and undertreated disease in Ophthalmology - Specsavers Clinical Conference, 11th October – Helsinki, Finland – late session for opticians/optometrists
  • Innovation and dry eye disease, invited by Integrated Training in Dry Eye Disease Drug Development, based on Marie Skłodowska-Curie EU Grant, EVER pre-meeting and youtube-interview, Nice, France, October 17, 2019
  • Dry eye disease for medical students, arranged by the Faculty of Medicine, UiO. Setting: Department of Ophthalmology, Oslo University Hospital, Oslo, Norway, October 24, 2019
  • Innovation, Innovation Camp for physiotherapy, Oslo Metropolitan University, Norway, October 28, 2019
  • Dry eye diseae, Seminar on "Healthy oral aging, an interdisciplinary approach" arranged by the Faculty of Dentistry, UiO. Setting: The Ekeberg restaurant, Oslo, Norway, October 29, 2019
  • Dry eye disease – an update, Clariton Hotel The Hub, Oslo, Norway, November 1, 2019, arranged by Santen
  • Ophthalmology meeting, arranged by Thea, Glostrup, Denmark, November 6, 2019
  • Dry eye diseae – topical therapy – what do we know at present time? European School of Advanced Studies in Ophthalmology (ESASO) meeting in Lugano, the Switzerland, November 18, 2019 
  • Dry eye disease, arranged by Thea, Billund, Denmark, December 11, 2019
  • Ophthalmology meeting, Aarhus, Denmark, arranged by Santen, January 9, 2020
  • Ophthalmology meeting, Copenhagen, Denmark, arranged by Santen, January 23, 2020
  • Innovation for biochemistry students, OsloMet, Norway, January 14
  • Stem cell therapy, innovation and dry eye disease, Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland, arranged by Professor Kai Kaarniranta, February 24, 2020

 

Various Scholarly Achievements in Chronological Order

 

  • 1998: Co-founder of “I Ragazzi”. This unit was responsible for writing MED NYTT, a booklet for medical students that was published monthly for many years, and organizing classical music concerts and film events at regular intervals for medical students at the Faculty of Medicine in Oslo, Norway
  • Disclosure of Invention (6 submitted since 2006; all accepted by Inven2, the largest Technology Transfer Office in Norway)
  • 2007: The first stem cell transplantation in Scandinavia using ex vivo cultured limbal epithelial cells was performed at the Department of Ophthalmology, Oslo University Hospital. To my knowledge, this transplantation was the first worldwide to include storage of cultured limbal epithelial cells for 4 days prior to the operation. The transplantation was based on research that resulted in a double PhD thesis on eye bank storage of cultured cells for Sten Ræder and me
  • Co-written a book of 133 pages; distributed to thousands of medical students in Norway and abroad since 2008 - Sten Ræder, Utheim TP, and Utheim OA: Ophthalmology – basal clinical examination, Unipub, Oslo, Norway, 2008 - present
  • 2010: Co-founder of a biotech company (Regena Medical AS) based on my own inventions in collaboration with Medinnova AS, which is now named Inven2
  • 2010–present: Reviewer for several scientific journals, including Progress in Retinal and Eye Research (impact factor: 11.5 ×1), Ocular Surface (impact factor: 9.1 ×3), Ophthalmology (impact factor: 8 ×1), Nanomedicine (5-year impact factor: 7 ×5), Stem Cells (impact factor: 5.5 ×1), , Scientific Reports (impact factor: 5.0 × 3), Stem Cells Translational Medicine (impact factor x 5), American Journal of Ophthalmology (impact factor: 4.5 x1), Stem CellResearch & Therapy (×1), Translational Vision Science & Technology (x 1), PLOS ONE (×1), IOVS (×2), Experimental Eye Research (×1), Acta Ophthalmologica (×2), Current Eye Research (×2), Journal of Materials Science (×2), Organogenesis (×1),  American Journal of Ophthalmology Case Reports (x 1), and Scandinavian Journal of Optometry and Visual Science (×1)
  • 2011–present: Associate member of the National Center for Stem Cell Research in Norway
  • 2011–2014: Classical music advisor for The Center for Studies of Holocaust and Religious Minorities, University of Oslo, Oslo, Norway
  • 2012: Co-founder of the first Dry Eye Clinic in Scandinavia. The research clinic has recently expanded nationally and internationally (Iceland) and received substantial funding for research from several sources, including the Norwegian Research Council, The Association for the Blind and Partially Sighted in Norway, a public hospital (Elverum, Norway), 8 pharmaceutical companies, and a private eye clinic in Iceland
  • 2011–present: Editorial board member for Medark, University of Oslo
  • 2012–present: Editorial board member for Oftalmolog, a Nordic journal of ophthalmology
  • 2012: Development of a software (A Dry Eye Management System, ADEMS) in collaboration with Sten Ræder to enable improved diagnostics of dry eye disease and analysis of data for quality assessment or research. The software has resulted in great interest from eye clinics both in Norway and abroad as well as from the pharmaceutical industry, resulting in substantial external funding to further develop the software
  • 2013–2015: Member of the Scientific Committee of Aniridia Europe
  • 2013–present: External examiner for 4 master’s theses
  • 2013–present: Regular columnist for the Norwegian journal Alt om Syn (“Everything About Vision”). Circulation: up to 700,000, 4 times yearly
  • 2014–present: Member of Network of Excellence in Corneal Regeneration, an EU research network based on EU funding (European Cooperation in Science and Technology [COST] Actions)
  • May 4, 2014: Moderator at ARVO (the world’s largest eye congress)
  • September 19, 2014: Expert panel member at the 2nd European Conference on Anirida, Italy
  • 2014–present: Editorial board member for Medical Hypothesis, Discovery & Innovation Ophthalmology Journal
  • Effective August 2014: Appointed “Innovation Contact” for several departments at Oslo University Hospital by the Head of Innovation at Oslo University Hospital My main task is to explore the innovative potential of research in these departments
  • 2014: Invited author of several review articles in several journals, including Journal of Functional Biomaterials(×3), Ophthalmology and Therapy (×1), and Medical Hypothesis, Discovery & Innovation Ophthalmology Journal(×1) (several manuscripts are currently in preparation)
  • Author of several popular scientific reports and commentaries, including “Iris,” “Technical Weekly Magazine,” “Everything about Vision” (several times), and in the Journal of the Norwegian Medical Association
  • December 2014: Board Member of NORBRAIN (Norwegian Brain Initiative; 14 members, including Nobel Prize Laureate Edvard Moser)
  • June 2014: Appointed Head of the Electron Microscopy Laboratory, Institute of Oral Biology, University of Oslo. The laboratory has 2.5 technicians. Since the last quarter of 2015, I have shared the position with Professor Linda Hildegard Bergersen
  • Submitted January 2015: Partner in EU application related to Innovation
  • January 9, 2015: Best grade “A” at the oral exam for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University
  • January 27, 2015: Interview on stem cells by Nature Biotechnology on regenerative medicine [Nature Biotechnology, 33 (3), March 2015]
  • March 5, 2015: Best grade “A” for thesis for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University. The head of the innovation program at The Norwegian Business School has included our thesis in the teaching material as an example of an outstanding thesis to inspire new classes
  • March 6, 2015: Accepted for the Research Leadership Programme at the University of Oslo for 2015
  • March 6, 2015: Head of a Strategy Committee on the role of innovation contacts at Oslo University Hospital (appointed by the Head of Innovation, Oslo University Hospital)
  • April 20, 2015–present: Editorial board member of International Journal of Experimental Dental Science
  • April 11, 2015: Invited as co-organizer of the Corneal Regenerative Medicine session at the Nordic Congress of Ophthalmology in Denmark in 2016, which included an invitation to appoint a keynote speaker
  • May 2015: Invited to be Moderator at ARVO
  • June 17, 2015: Assessed as Professor Competent at the Faculty of Medicine, University of Oslo, at the first attempt of such evaluation (CV submitted January 17, 2015, at the age of 38 years). The assessment report concludes: “He is an ideal clinician-scientist with large potential to make major contributions in translational medical research.”
  • June 19, 2015: External examiner of one PhD thesis
  • July 20, 2015: Invited by the organizers of the 2016 Nordic Congress of Ophthalmology in Denmark to give a talk entitled “How to fast track your research career?” based on recent academic progress
  • August 28, 2015: Appointed as assessment committee member to select the best publication during the first 6 months of 2016 from the Division of Diagnostics and Intervention, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo
  • October 19, 2015: Co-organizer and co-chair for the Oslo University Research Seminar
  • December 7, 2015: Member of the 3rd Aniridia Europe Conference Scientific Organizer Committee
  • October 2015: Appointed member of the advisory/working group of the Director of Innovation of the Southern Eastern Norway Regional Health Authority
  • October 2015: Appointed project leader for the test lab project in collaboration with Oslo University Hospital and the municipality of Oslo
  • 2016: The only employee of the University of Oslo Faculty of Dentistry nominated for the University of Oslo Innovation Prize
  • 2016: Abstract nominated by the organization committee of the European Society of Ophthalmology for best poster award (co-author contribution)
  • May 2016: Invitation to serve as moderator for 3 corneal sessions (paper: 267 - Corneal Epithelium Health and Disease, poster: 144 - Corneal Regenerative Medicine, poster: 439 - Corneal refractive surgery II) at ARVO, Seattle, TX
  • 2016: Invited to serve as Lead Guest Editor for a Special Issue of Journal of Ophthalmology
  • 2016: Appointed member of the Innovation Advisory Board, Oslo University Hospital
  • June 8, 2016: Moderator of 2016 Oslo Dental Science Forum, Oslo Congress Center, Oslo, Norway
  • August 25, 2016: Appointed “Innovation Contact” (i.e., responsible for innovation) for the Clinic of Laboratory Medicine, Oslo University Hospital. The Clinic of Laboratory Medicine is the largest clinic at the Institute of Clinical Medicine, Oslo University Hospital
  • 2016 - 2017: Examination committee member, Faculty of Dentistry, University of Oslo (the work consists of planning, writing, and correction of exams)
  • January 1, 2017: Appointed Editor-in-Chief for Oftalmolog
  • February 24, 2017: Appointed Norway Ambassador for the Tear Film & Ocular Surface Society. Only one ambassador is appointed from each country
  • March 25, 2017: Reviewer for Biotechnology and Biological Sciences Research Council (BBSRC), the lead funding agency for academic research and training in the biosciences at universities and institutes throughout the UK
  • May 4, 2017: Granted EU funding: Horizon 2020—Research and Innovation Framework Programme. Project title: Functional Hybrid Coatings by Molecular Layer Deposition (consortium member)
  • May 6, 2017: Member of the Novartis Global Ocular Surface Advisory Board
  • May 2017: Appointed member of the organizing committee and scientific committee for the Nordic Congress of Ophthalmology 2018 in Oslo, Norway
  • May 2017: Invitation to serve as moderator for the dry eye disease and the corneal regenerative medicine paper session at the Nordic Congress of Ophthalmology 2018 in Oslo, Norway
  • May 7-11, 2017: Moderator for 2 scientific sessions (dry eye disease and corneal biomechanics) at ARVO, Baltimore, US
  • June 2017, Co-founder of Velotrail AS (company devoted to innovations related to bike security—6 co-founders, including previous Oslo University Hospital Director of Innovation, Kari Kværner)
  • September 2017 to February 2018: Leadership development program, Oslo University Hospital
  • April 2018: Appointed professor in innovation at Oslo Metropolitan University, Oslo, 2018 (the first and currently only professorship in innovation at Oslo Metropolitan University)
  • April 30, 2018: Moderator for a paper session (Dry Eye Clinical) at ARVO, Honolulu, Hawaii
  • May 2, 2018: Moderator for a poster session at ARVO (Dry Eye Clinical II), Honolulu, Hawaii
  • August 9, 2018: Member of the evaluation committee for Oslo Metropoltian University Innovation Award of NOK 80,000. The other members were Kristin Sverdrup, Director of Research, Oslo Metropoltian University Hospital and Christian Bjerke, Director of Innovation for Simula Innovation (https://www.simula.no)
  • August 18, 2018: Moderator, the Norwegian Center for Stem Cell Research, Oslo, Norway
  • August 20, 2018: Consultant, Mundipharma AS, Dicks vei 10B, 1366 Lysaker, Norway
  • August 10, 2018: Invited as Keynote Speaker on innovation at Oslo Metropoltian University Hospital in November 2018. Title: Innovation – what, why and how.
  • Consortium member of the EU network COST ANIRIDIA-NET (accepted on November 15, 2018)
  • Consultant, Stratas-Partners AS, Elisabethenanlage 25 - CH 4051 Basel, December 17, 2018
  • Head of the PhD evaluation committee for Miriam Landfors at the Faculty of Medicine, University of Oslo, Jan 26, 2018
  • Five invitations as moderator at ARVO 2019, whereof three accepted (February 16, 2019)
  • Member of Board of Directors of the International Ocular Surface Society (established in 1998). Others members of this board are: Cintia S. De Paiva, MD, PhD – IOSS President, Stephen C. Pflugfelder, MD, Margarita Calonge, MD, PhD, Darren G. Gregory, M.D, Andrew JW Huang, MD, Koray Gumus, MD, FEBOphth, Winston W-Y Kao, Ph.D., VK Raju, M.D., F.R.C.S., F.A.C.S., Saaeha Rauz, PhD FRCOphth, Abraham (Avi) Solomon, M.D.,Michael E. Stern, Ph.D.,John E. Sutphin, MD, Ray Jui-Fang Tsai, M.D., Scheffer C. G. Tseng, MD, PhD. Professor Kazuo Tsubota (March 15, 2019 - present) 
  • Internatinal member of the Lid and Meibum Gland Working Group - LIME (http://www.lime.jp) (May 1, 2019 - present)
  • Moderator Santen Losby Symposium (one full day), October 25, Losby Gods, Losbyveien 270, 1475 Finstadjordet
  • Members of Board of Directors of Sirens group, Stavanger University Hospital, Norway (invited by the Director of Research of the university hospital), March 2020
  • Jury Member of the Aniridia Europe Research Award of 2020 (invited by the President of Aniridia Europe), April 2020

 

Publications

Popular Science 

1. Rygh M, Utheim TP, Ræder S: Utposten [Dry Eyes], (Norwegian Medical Journal), 2013

2. Eidet JR, Utheim TP: [Treatment of Conjunctival Disorders with Transplantation], Oftalmolog, Issue 3, 2013, 6-7

3. Utheim TP, Utheim OA, Reader S, Lyberg T, Eidet JR: [Treatment of Limbal Stem Cell Deficiency – What is possible in 2014?], Oftalmolog (Nordic Journal of Ophthalmology), 2014, 4, pp.3-6

4. Utheim TP, Utheim OA, Raeder S, Messelt E, Eidet JR: The role of mucosal cells in treating blindness (review) Oftalmolog, March 2015.

5. Utheim TP, Sommer-Landsend E, Utheim OA: Aniridia (review) Oftalmolog, March 2015

6. Utheim TP, Utheim OA, Eidet JR, Raeder S, Jackson C, Sehic A: Transplantation of Skin to the Eye – What is the Status 122 Years after the First Transplantation? - Oftalmolog, September; December 2015; (4) 17-19

 

Scientific Abstracts 

 

Presentations at Professional Meetings (Published in Peer-Reviewed Journals)

1. Raeder S, Utheim TP, Ramstad H, Cai Y, Stoelen S, Baerland TP, Utheim OA, Messelt E, Lyberg T, Nicolaissen B: Engineering of Multilayered Polarized Epithelial Grafts From Explant Culture Is Independent of Limbal Explant Orientation. Invest. Ophthalmol. Vis. Sci. 2006 47: E-Abstract 3017

2. Utheim TP, Raeder S, Utheim OA, et al. Storage of Cultured Limbal Epithelial Cells at 23ºC and 31ºC in Organ Culture Medium and at 5ºC in Optisol-GS: A Light Microscopy and Phenotypic Study. Invest. Ophthalmol. Vis. Sci. 2007 48: E-Abstract 460

3. Prabhakar S, Utheim TP, Raeder S, et al. Apoptosis Gene Expression Profiling of Ex Vivo Expanded Human Limbal Epithelial Cells. The FASEB Journal 2007;21:lb56

4. Raeder S, Utheim TP, Utheim OA, et al. Eye Bank Storage of Cultured Corneal Epithelium: Sterility Testing of Storage Media, Long-Term Preservation, and Deepithelialization of the Amniotic Membrane Substrate Invest. Ophthalmol. Vis. Sci. 2008 47: E-Abstract 5717

5. Utheim TP, Raeder S, Utheim OA, et al. Identification of Predilection Target Sites for Tissue Harvesting in Corneal Epithelial Tissue Engineering Ophthalmol. Vis. Sci. 2008 47: E-Abstract 5746

6. Utheim TP, Raeder S, Eide JR, et al. Storage of Cultured Human Limbal Epithelial Cells in Optisol-GS at 23°C versus 5°C Invest. Ophthalmol. Vis. Sci. 2009 E-abstract 1778

7. Raeder S, Utheim TP, Olstad OK, et al. Genome-Wide Transcriptional Analysis of Cultured Human Limbal Epithelial Cells Following Hypothermic Storage in Optisol-GS Invest. Ophthalmol. Vis. Sci. 2009 E-abstract 1773

8. Eidet J, Fostad IG, Shatos M, Utheim TP et al. Effect of Biopsy Location and Size on Phenotype and Proliferative Ability of Cultured Rat Conjunctival Tissue. Invest. Ophthalmol. Vis. Sci. 2010 E-abstract 1912

9. Engelsvold DH, Ulltveit-Moe HF, Olstad OK, Utheim TP, et al: The MicroRNA And MessengerRNA Gene Expression Signature Of Human Primary Pterygium, ARVO 2011

10. Ulltveit-Moe HF, Eidet JR, Björkblom B, Møller S, Utheim TP, et al: Xenobiotic- and Serum-Free Culture Protocol for Autologous Cultivated Oral Mucosal Epithelial Cells on 

Contact Lenses, ARVO 2011

11. Utheim TP, Utheim OA, Eidet J et al: Comparison of Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM, Optisol-GS and PAA Quantum 286 for 4 days at 23°C, ARVO 2011

12. Pasovic L, Eidet JR, Aabel P, Messelt E, Lyberg T, Chen X, and Utheim TP. Effect of storage temperature on the viability of cultured retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract 

13. Prener JP, Eidet JR, Utheim TP; Bragadottir R. Ultra-Widefield Retinal Autofluorescence Patterns in Patients with Autosomal Dominant Retinitis Pigmentosa and Stargardt’s Disease. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract

14. Chen X, Stojanovic A, Zheng L, Zhang J, Stojanovic F, Wang Q, Utheim TP. One-step transepithelial topography-guided ablation in treatment of myopic astigmatism. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract

15. Utheim TP, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T. Transportation simulations of cultured human limbal epithelial cells subjected to eye-bank storage. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract

16. Utheim TP, Edén U, Lagali N, Dellby A, Riise R, Chen X, Fagerholm P: In Vivo Morphology of the Limbal Palisades of Vogt Correlates with Progressive Stem Cell Deficiency in Aniridia-Related Keratopathy. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract 

17. Storr-Paulsen T; Fullana M; Wang A; Karamichos D; Utheim TP; Shatos MA; Hjortdal J; Wnek GE; Dartt DA: Use of Polymeric Scaffolds as Extracellular Matrix Substitutes for Conjunctival Epithelial Repair. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract 

18. Rygh OM; Eidet JR; Chen X; Utheim TP, Thyholdt A; Utheim OA; Stojanovic F; Stojanovic A; Raeder S: Symptoms and Findings in a Norwegian Cohort of Patients with Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract

19. Eidet JR, Utheim TP, Utheim OA, Chen X, Stojanovic A, Dartt DA, Raeder S Improved Staining, Tear Film Breakup Time, and Dry Eye Severity Level Following a Six-Month Treatment of a Cohort of Dry Eye Patients in Norway. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

20. Badian R, Raeder S , Utheim TP, Utheim OA, Chen X, Stojanovic A, Dartt DA, Eidet JR.  Age-associated Differences in Severity of Ocular Signs in Dry Eye Disease Patients Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

21.  Fostad I, Eidet JR, Raeder S, Lagali N, Messelt E, Jensen J, Galtung H, Utheim TP: Dry Eye Disease Patients with Xerostomia Report Higher Symptomatic Burden. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

22. Salvanos P, Utheim TP, Moe MC, Eide N, Bragadottir R: Autofluorescence Pattern of Optic Disc Melanocytoma. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

23. Parissi M, Randjelovic S, Wihlmark TB, Utheim TP, and Lagali N: Corneal subbasal nerve morphology and regeneration in keratoconus and 4 years after UVA-riboflavin collagen cross-linking. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

24. Utheim TP, Fricke O, Lagali N: Distinct ‘microdot’ structures accumulate in the cornea with age. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract

25. Jackson C, Aabel P, Eidet JR, Messelt E, Lyberg T, Utheim TP: Xenobiotic Free Storage of Cultured Epidermal Cell Sheets for 14 Days – the Effects of Temperature on Viability, Morphology, Phenotype and Metabolic status. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract 

26. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: RvD1 and RvE1 in Epithelial Goblet Cell Function, New York Academy of Science Conference, New York, U.S., 2014

27. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA. Clonal Growth Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue. Experimental Biology conference, San Diego, 2014

28. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: Differential Effect of Pro-resolution Mediators Resolvins RvD1 and RvE1 on Conjunctival Goblet Cell Function. ARVO, US, 2014 

29. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA: Culture Media and Biopsy Location Effect the Proliferative Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue. ARVO, US, 2014 

30. Badian R, Utheim TP, Allgeier S, Köhler, B; Ruggeri, A, Poletti E, Guimarães P, Lagali S: Quantitative Analysis of Corneal Sub-basal Nerve Plexus and Inflammatory Cells in Large-area Mosaics Obtained by In Vivo Confocal Microscopy ARVO, US, 2014 

31. Utheim TP, Islam R, Fostad I, Dartt DA, Olstad OK, Sehic A, Eidet JR: Impact of Storage Temperature on Gene Expression of Cultured Oral Mucosal Cells, ARVO, US, 2014 

32. Utheim TP, Utheim OA, Raeder S, Lyberg T, Messelt E, Jackson C, Islam R, Eidet JR:  Stem Cell Therapy of the Ocular Surface – Current Possibilities and Limitations: Kongsberg Vision Meeting, Kongsberg, Norway, 2014 (oral presentation)

33.  Fostad, IG; Eidet JR, Lyberg T, Olstad OK, Utheim TP, Mikkelsen K; Wiik A, Hollan A The Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis may be related to Nupr1 activation: EULAR Conference, Zürich, Switzerland, 2015 Annals of the Rheumatic Diseases (Impact Factor: 10.38) 06/2015; 74(Suppl 2):686.1-686. 10.38:

34. Eidet JR, Utheim TP, Lyberg T, Kaass A, Mikkelsen K, Veel T, Saatvedt, Fagerland MW, Hollan I: Level of adiponectin in rheumatoid arthritis is associated with coronary artery disease, EULAR Conference, Zürich, Switzerland, 2015, Publication in Annals of the Rheumatic Diseases (Impact Factor: 10.38). 06/2015; 74(Suppl 2):449.2-450.

35. Utheim TP, Wendel J, Jackson C, lslam R, Ræder S, Sehic A, Eidet JR: Innovative strategies for treating stem cell deficiency of the ocular surface, Kongsberg Vision Meeting 2015 (submitted) 

36. Badian R, Utheim TP, Raeder S, Utheim OA, Chen X, Stojanovic A, Eidet JR. Effects of contact lens use in a cohort of dry eye disease patients. Kongsberg Vision Meeting 2015 (submitted) 

37. Jackson C, Eidet JR, Reppe S, Eide L, Tønseth KA, Bergesen LR,  Dartt DA, Griffith M, and Utheim TP: Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Human Epidermal Cell Sheets. Kongsberg Vision Meeting 2015 

38. Rakibul Islam, Darlene A. Dartt, Jon R. Eidet, Marit Lippestad, Edward Messelt, May Griffith, Tor P. Utheim: The effects of culture parameters on ex vivo expansion of oral mucosal cells. Kongsberg Vision Meeting 2015

39. Eidet JR, Ræder S, Chen X, Badian RA, Utheim OA, Utheim TP: The Four Seasons of Dry Eye Disease Seasonal Variations in Presenting Symptoms and Signs of Dry Eye Disease in Norway (European Association for Vision and Research, Nice, October 7-10, 2015)

40. Badian, Utheim, Allgeie S, Köhler R, Lagali N: Quantitative analysis of Central Corneal Sub-basal Inflammatory cells/Dendritic Cells in Large-area Mosaic images obtained by In Vivo Confocal Microscopy (IVCM), Invest. Ophthalmol. Vis. Sci. 2016 E-abstract,

41 Reppe, Chen X, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Tashbayev B: Clinical Findings of Dry Eye Disease in a Large Norwegian Cohort Based on Osmolarity Measurements Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

42. Eidet JR, Ræder S, Chen X, Badian RA, Utheim OA, Utheim TP: Dry Eye Disease Therapy: who are the non-responders? (European Association for Vision and Research, Nice, October 7-10, 2015)

43. Utheim OA, Ræder S, Eidet JR, Utheim TP, Badian RA, Stojanovic A, Chen X: Efficacy of Dry Eye Disease Treatment based on the 2007 Report of the International Dry Eye WorkShop (DEWS) (European Association for Vision and Research, Nice, October 7-10, 2015)

44. Badian R, Eidet JR, Ræder S, Utheim OA, Chen X, Stojanovic A, Utheim TP: Correlation of Osmolarity Measurements with Signs and Symptoms in a Norwegian Cohort of Patients with Dry Eye Disease (European Association for Vision and Research, Nice, October 7-10, 2015)

45. Badian R, Eidet JR, Ræder S, Utheim OA, Chen X, Stojanovic A, Utheim TP: Advancing age does not strongly correlate with symptoms and signs of Dry Eye Disease in a large Norwegian cohort (European Association for Vision and Research, Nice, October 7-10, 2015)

46. Pasovic L, Utheim TP, Reppe S, Lyberg T, Olstad OK, and Eidet JR: The Silk-protein Sericin Induces Rapid Melanization of Cultured Retinal Pigment Epithelial Cells by Activating the NF-kB Pathway (European Association for Vision and Research, Nice, October 7-10, 2015)

47. Pasovic L, Eidet JR, Olstad OK, Chen DF, Lyberg T and Utheim TP:

Impact of Storage Temperature on Gene Expression of Cultured ARPE-19 Cells (European Association for Vision and Research, Nice, October 7-10, 2015)

48. Eidet  JR, Fostad IG, Shields K, Lyberg  T, Utheim TP,  Kåss  A,  Mikkelsen  K, Veel T,  Saatvedt K, Fagerland M, Liang M, Hollan I: A low adiponectin level in rheumatoid arthritis is associated with coronary artery disease; ACR/ARHP Annual Meeting, San Francisco, CA; November 6-11, 2015

49. Fostad IG, Eidet JR, Lyberg T, Olstad OK, Utheim TP, Mikkelsen K, Wiik A, Hollan I. The Transcription Factor NUPR1 may Contribute to Increased Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis; ACR/ARHP Annual Meeting, San Francisco, CA; November 6-11, 2015

50. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines Presented at The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

51. Mohammed A, Xiao J, Olafsson J, Raeder S, Utheim TP, Utheim OA, Lagali N, Dartt DA, Chen X: Subjective and Objective Assessment of Meibography Images Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

52. Landsend E, Utheim OA, Pedersen H, Baraas R, Dartt DA, Lagali N, Utheim TP: Dry Eye Disease in a Norwegian-Danish Cohort of Congenital Aniridia, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

53. Xiao J, Mohammed A, Olafsson J, Raeder S, Utheim TP, Utheim OA, Lagali N, Dartt DA, Chen X: Morphological Evaluation of Meibomian Glands in Eyes with Dry Eye Disease, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

54. Pedersen H, Hagen LA, Landsend E, Gjelle J, Utheim OA, Gilson SJ, Utheim TP, Baraas R. Color vision, dark adaptation and retinal structure in Aniridia, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract

55. Eidet JR, Tashbayev B, Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Pollen Count Compared with Severity of Symptoms and Signs of Dry Eye Disease in Norway, EVER, October 5-8, 2016 

56. Khan A, Utheim TP, Reppe S, Sandvik L, Lyberg T, Roald B, Eidet JR: Optimization of Storage of Differentiated Retinal Pigment Epithelial Cells, EVER, October 5-8, 2016 

57. Reppe, Chen X, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Tashbayev B: Clinical Findings of Dry Eye Disease in a Large Norwegian Cohort Based on Osmolarity Measurements Invest. Ophthalmol. Vis. Sci. 2016 E-abstract 

58. Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Utheim TP: Correlation between clinical parameters from the right and left eyes of a Norwegian cohort of dry eye patients, Kongsberg Vision Meeting 2016, Norway

59. Chen X, Stojanovic A, Raeder S, Utheim TP: Medium- to Long-Term Results of Corneal Cross-Linking for Keratoconus Using Phototherapeutic Keratectomy for Epithelial Removal and Partial Stromal Ablation, Kongsberg Vision Meeting 2016, Norway

60. Xu Y, Chen X, Zhou W, Utheim TP, Stojanovic A: Comparison of Pachymetry Measurements Using Two Optical Coherence Tomography Devices and Rotating Scheimpflug Imaging in Eyes with Keratoconus, ESCRS, 2016

61. Lagali N, Wowra B, Darek T, Utheim TP, Wylegala E, Fagerholm P: The progressive phenotype of aniridia-associated keratopathy in a Polish cohort – therapeutic implications, ARVO, Baltimore, US, 2017 

62. Badian R, Utheim TP, Allgeier S, Liu X, Köhler B, Lagali N: Quantification of Inflammatory Cells in the Corneal Sub-basal Layer in Type 2 Diabetes by In Vivo Confocal Microscopy (IVCM), ARVO, Baltimore, US, 2017 

63. Dartt DA, Botten N, Hodges R, Dayu L, Bair  J, Shatos M, Utheim TP, Serhan CN: Resolvin D2 Increases Conjunctival Goblet Cell Intracellular [Ca2+] by Increasing Cellular cAMP Levels and Activating Protein Kinase A, ARVO, Baltimore, US, 2017 

64. Tashbayev B, Rusthen S, Chen X, Utheim O, Young A, Herlofson BB, Utheim TP, Jensen JL Interdisciplinary evaluation of patients with primary sjögren’s syndrome. ARVO, Baltimore, US, 2017 

65. Landsend ES, Pedersen H, Utheim OA, Hans Christian Aass, Tashbayev B, Lagali N, Dartt DA, Barass R, Utheim TP: Tear Cytokine Profile in a Scandinavian Cohort of Congenital Aniridia: ARVO, Baltimore, US, 2017 

66. Cho KS, Xiao J, Adil MY, Utheim, TP, Chen, DF:
Contrast sensitivity threshold correlates to the progressive degeneration of photoreceptors in a mouse model of retinitis pigmentosa.
ARVO, Baltimore, US, 2017

67. Tashbayev B, Raeder S, Chen X, Stojanovic A, Utheim OA, Utheim TP: Utility of tear osmolarity measurement in diagnosis of dry eye disease; European Society of Ophthalmolgy, June 2017 

68. Fjærvoll K, Yazdani M, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Preservative-Free Eye Drops for Dry Eye Disease! How about Eye Cosmetics?! - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

69. Fjærvoll H, Yazdani M, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Eye Cosmetic Products and a Known Eye Irritant - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

70. Raja SI, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Tear Osmolarity Measurements in a Norwegian Cohort of Patients with Clinically Evident Dry Eye Disease - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

71. Olafsson J, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Interocular Difference in Tear Film Break-up Time in a Norwegian Cohort of Dry Eye Patients - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

72. Kaurstad M, Utheim OA, Chen X, Utheim TP, Ræder S, Tashbayev B: Characteristics of Dry Eye Disease in Two Different Age Groups in a Norwegian Cohort of Dry Eye Patients, Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

73. Espelid I, Utheim TP, Xiangjun Chen, Ræder S, Utheim OA, Dartt DA, Tashbayev B: Assessment of Dry Eye Related Quality of Life in a Norwegian Cohort of Dry Eye Patients, Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

74. Yazdani M, Chen X, Tashbayev B, Utheim OA, Ræder S, Lagli N, Stojanovic A, Dartt DA, Utheim TP: Tear production levels and dry eye disease severity in a large Norwegian cohort - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

75. Tellefsen S, Stojanovic A, Utheim TP, Tashbayev B, Raeder S, Chen X: Gender differences in symptoms and signs of dry eye disease in patients under 40 years old - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway

76. Tashbayev B, Rusthen S, Chen X, Utheim TP, Utheim Ø, Young A, Herlofson BB, Aqrawi LA, Rykke M, Hove LH, Palm Ø, Jensen JL: Dry Mouth and Dry Eye Examinations of a Norwegian Cohort of Primary Sjögren´s Syndrome Patients, The 64th Congress of the European Organisation for Caries Research 2017, Oslo, Norway

77. Hilde R. Pedersen, Jon V. Gjelle, Lene A. Hagen, Erlend C. Landsend, Stuart J. Gilson, Øygunn A. Utheim, Tor P. Utheim, Rigmor C. Baraas: Investigations of ocular biometry in patients with congenital aniridia. Kongsberg Vision Meeting, Kongsberg, Norway

78. Badian RA, Utheim TP, Ræder S, Utheim ØA, Chen X, Tashbayev B, Aakre BM,  Ystenæs AE, Sundling V: Title: Prevalence of MGD in a Norwegian Working Age Population Seeking Specialist Eye Care for Dry Eye Symptoms; ARVO, Hawaii, April 29 - May 3, 2018 

79. Olafsson, J; Utheim, OA, Chen, X; Olafsson, S; Raeder, S; Dartt DA; Tashbayev B; Utheim, TP: Changes in Signs and Symptoms of Dry Eye Disease after using 0.1% and 0.05% Emulsions of Cyclosporine A Eye Drops; ARVO, Hawaii, April 29 - May 3, 2018 

80. Reppe S, Jackson CJ, Ringstad H, Bakke H, Tønseth KA, Eidet JR, Utheim TP: Factorial design in regenerative medicine – high throughput screening of additives to promote survival of stored undifferentiated epidermal cells; ARVO, Hawaii, April 29 - May 3, 2018 

81. Jackson CJ, Yazdani M, Reppe S, Tønseth KA, Thiede B, Utheim TP: Proteomic Analysis Indicates Activation of Cell Protective and Energy Conservation Mechanisms in Cultured Sheets Stored at 12°C: ARVO, Hawaii, April 29 - May 3, 2018 

82. Enayati S, Cho K, Utheim TP, Chen DF: Electrostimulation promotes Muller glial cell proliferation: ARVO, Hawaii, April 29 - May 3, 2018 

84. Pedersen H, Neitz J, Gilson SJ, Landsend ES, Utheim OA, Utheim TP, Baraas R: Retinal structure variation in congenital aniridia: within family phenotype-genotype discordance ARVO, Hawaii, April 29 - May 3, 2018

85. Landsend ES, Utheim OA, Pedersen HR, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP: Fundus Autofluorescence in Congenital Aniridia; ARVO, Hawaii, April 29 - May 3, 2018

86. Cho KS, Xiao J, Shi C, Chang K, Utheim TP, Luo G, Chen DF: Comparison of computerized system and human observers for vision assessment based on optomotor response in Rhodopsin knockout mice, ARVO, Hawaii, April 29 - May 3, 2018

87. Dartt DA, Lippestad M, Hodges R, Utheim TP, Serhan C: Resolvin E1 uses multiple receptors and signaling pathways to increase intracellular Ca2+ and mucin secretion in conjunctival goblet cells, ARVO, Hawaii, April 29 - May 3, 2018

88. Dartt DA, Bair J, Olsen M, Hodges R, Utheim TP, Serhan C: Comparison of Signaling Pathways used by the Specialized Pro-Resolving Mediators Maresin1- and Maresin-2 to Regulate Conjunctival Goblet Cell Function, ARVO, Vancouver, BC, April 28 - May 2, 2019

89. Lagali L, Wowra B, Fries F, Latta L, Utheim TP, Wylegala E, Seitz B, Käsmann-Kellner B: Early ocular surface changes in aniridia-associated keratopathy - insights from anterior segment imaging in children, ARVO, Vancouver, BC, April 28 - May 2, 2019

90. Sam Enayati1,2, Hamida Achour1,2, Kinsang Cho1,3, Lu Lu4, Fuyi Xu4, Tor Paaske Utheim1,2, Dong Feng Chen1 Electrostimulation improves progenitor cell potential of Muller glial cells, ARVO, Vancouver, BC, April 28 - May 2, 2019

91. Pedersen H, Neitz N, Gilson S, Landsend ES, Utheim OA, Utheim TP, Baraas RC: PAX6 genotype and thickness of retinal layers in aniridia, ARVO, Vancouver, BC, April 28 - May 2, 2019

92. Badian R, Utheim TP, Lagali NS: Length Density (mCNFL) in the Corneal Sub-basal Layer in Type 2 Diabetes (T2DM), based on Analysis of Region of Interest (ROI), ARVO, Vancouver, BC, April 28 - May 2, 2019

 

Presentations at Professional Meetings (not Published)

 

1. Raeder S, Utheim TP, Ramstad H, Cai Y, Stoelen S, Pedersen TP, Utheim OA, Messelt E, Lyberg T, Nicolaissen B: Engineering of multilayered polarized corneal epithelial grafts from explant culture. XXXVII Nordic Congress of Ophtalmology, Copenhagen, Denmark 2006

2. Utheim TP, Ræder S, Utheim ØA, Cai Y, Roald B, Lyberg T, Kjeldsen-Kragh J, Ramstad H, Messelt E, Nicolaissen B: The effect of limbal explant orientation on the phenotype and barrier function of cultured limbal epithelial cells. European Eye Bank Association, XIX. Annual Meeting, Bratislava, Slovakia, 2007

3. Utheim TP, Raeder S, Utheim OA, Eidet JR, Roald B, Lyberg T: A novel method of preserving cultured limbal epithelial cells. European Eye Bank Association, XIX. Annual Meeting, Bratislava, Slovakia, 2007

4. Raeder S, Utheim TP, Utheim OA, et al. Effects of the size of explants on adhesion and outgrowth of ex vivo expanded limbal epithelial cells, XXXVIII Nordic Congress of Ophtalmology, Tromsoe, Norway, 2008

5. Raeder S, Utheim TP, Utheim OA, et al. The rationale of transplantation of preserved cultured limbal epithelial cells: Possibilities and limitations, XXXVIII Nordic Congress of Ophtalmology, Tromsoe, Norway, 2008

6. Utheim TP, Raeder S, Utheim OA, et al. Effects of the size of explants on epithelial thickness, number of cell layers, ultrastructure, and phenotype of cultured limbal epithelial cells. European Eye Bank Association, Annual Meeting, Amsterdam, The Netherlands, 2009 

7. Eidet J, Utheim TP, Utheim OA, Lyberg T: Effects of ExtraCellular Matrix Proteins on Adhesion of Cultured Human Retinal Pigment Epithelial Cells, EVER 2010.

8. Utheim TP, Eidet J, Utheim OA, Lyberg T: Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM at 23°C, EVER 2010

9. Utheim TP Eidet JR, Utheim OA, Raeder S, Dartt DA, Roald B Carreras E, Huynh TH, Messelt E, Louch WE, Lyberg T. Effects of Serum-free Eye Banking on Morphology, Phenotype, and Viability of Ex Vivo Cultivated Human Conjunctival Epithelium, EUCornea, 2011

10. Lagali N, Eden U, Utheim TP, Chen X, Riise R, Dellby A, and Fagerholm P: Morphologic investigation of the limbal stem cell niche in aniridia by in vivo confocal microscopy, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki 

11. Edén U, Lagali N, Fagerholm P, Dellby A, Utheim TP, Riise R: Cataract, cataract surgery and Keratopathy in patients with congenital aniridia, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki 

12. Engelsvold D, Utheim TP,  Olstad OK, Lyberg T, Gonzalez P, Dartt DA. Raeder S:

MicroRNA And mRNA Gene Expression Signature Identifies miR-200 family as Potential Regulator of Epithelial-Mesenchymal Transition in Primary Pterygium, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki 

13. Utheim TP Raeder S, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T.  Treating limbal stem cell deficiency without applying limbal stem cells 1st European Conference on Aniridia, Oslo, Norway, 2012

14. Utheim TP, Raeder S, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T.:  Storage and transportation of cultured limbal and conjunctival epithelial cells for ocular surface reconstruction; 1st European Conference on Aniridia, Oslo, Norway, 2012

15. Eden U, Riise R, Tornquist K, Lagali N, Utheim TP, Chen X, Fagerholm P: How does the eye status in aniridia evolve with time? 1st European Conference on Aniridia, Oslo, Norway, 2012

16. Utheim TP, Utheim OA, Eidet JR, de la Paz M, Roald B, Dartt DA, Lyberg T. The impact of storage temperature and storage media on cultured human limbal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012

17. Utheim TP, Utheim OA, Eidet JR, Messelt E, de la Paz M, Roald B, Dartt DA, Lyberg T. A novel transportation system for cultured human limbal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012

18. Utheim TP, Pasovic L, Messelt E, Lyberg T, Chen DF, Aabel P, Chen X and Eidet JR Preservation of cultured human retinal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012

19. Utheim TP: The role of stem cells in ocular surface reconstruction" SOE Congress, Copenhagen, Denmark (SOE lecturer poster), 2013

20. Utheim TP, Eidet JR, Chen X, Utheim OA, Rygh OM, Thyholdt A, Stojanovic F, Stojanovic A, Raeder S: Comparison of symptoms and signs of Norwegian dry eye disease patients with and without meibomian gland dysfunction" SOE Congress, Copenhagen, Denmark, 2013

21. Chen X, Stojanovic A, Stojanovic F, Wang J, and Utheim TP: The contribution of the Posterior Corneal Surface to the Total Corneal Astigmatism XXXI Congress of the ESCRS, Amsterdam, The Netherlands, 2013 

22. Chen X, Stojanovic A, Wang J, Hua Y, Jiang T, Zhang T and Utheim TP: Repeatability and Reproducibility of Corneal Biomechanical Measurement with Dynamic Scheimpflug Analyzer XXXI Congress of the ESCRS, Amsterdam, The Netherlands, 2013 

23. Eidet JR, Chen X, Utheim TP, Utheim OA, Stojanovic A, Stojanovic F, Raeder S:  Correlations between severity of dry eye symptoms and the use of systemic prescription drugs in a cohort of dry eye patients. TFOS, Sicily, Italy, 2013

24. Badian R, Eidet JR, Raeder S, Utheim OA, Chen X, Stojanovic A, Utheim TP. Prevalence of Meibomian Gland Disorder in a Cohort of Norwegian Dry Eye Disease Patients, Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014

25. Badian R, Utheim TP, Raeder S, Utheim OA, Chen X, Stojanovic A, Eidet JR. Contact lenses and dry eyes. Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014

51. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Lower Vital Staining Score and Increased Tear Film Break-Up Time One Year After Initiation of Treatment of Dry Eye Disease. Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014

26. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Ocular Protection Index is related to Ocular Surface Disease Index in Dry Eye Disease Patients European Association for Vision and Eye Research, Nice, France, 2014

27. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Evaluation of Self-report Questionnaires as Predictive Tests for Obtaining Pathological Schirmer I, Tear Film Break-up Time and Ocular Protection Index Scores in Dry Eye Disease Patients European Association for Vision and Eye Research, Nice, France, 2014 

28. Salvanos P., Bragadóttir R., Stene-Johansen I., Moe M.C., Utheim T.P.. Long-term follow-up of bomb explosion injury with fundus autofluorescence imaging. SOE2015, Vienna 6-9 June 2015   

29. Utheim TP, Jackson C, Eidet JR, Messelt E, Corroya RM, Lyberg T, Griffith M, Dartt DA; Islam R:  Effect of Storage Temperature on the Viability, Phenotype, Metabolism and Morphology of Cultured Human Oral Keratinocytes, 2nd European Conference on Aniridia, Venice, Italy, 2014 (selected for oral presentation)

30. Jackson C, Aabel P, Eidet JR, Lyberg T, Messelt E, Utheim TP: Treating blindness by means of cultured epidermal cells. The Norwegian Ophthalmology Society, Oslo, Norway, 2014 (oral presentation)

31. Jackson C, Aabel P, Eidet JR, Messelt E, Lyberg T, Utheim TP: The rationale for transplanting epidermal cells onto the cornea to treat blindness - Latest progress in culture and storage of epidermal cells (oral presentation). Norwegian Center of Stem Cell Research, Oslo, Norway, 2014

32. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA. Effects of Culture Media and Biopsy Location on Proliferative Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue: Cornea Center of Excellence Faculty Scientific Retreat, Harvard Medical School, Boston, US, 2014

33. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: Differential Effect of Pro-resolution Mediators Resolvins RvD1 and RvE1 on Conjunctival Goblet Cell Function: Cornea Center of Excellence Faculty Scientific Retreat, Harvard Medical School, Boston, US, 2014

34. Fagerholm P, Eden U, Lagali N, Dellby A, Ihnatko, Utheim TP, Chen X, Riise R: Aniridia Associated keratoplasty: Is it time to evaluate treatment? 2nd European Conference on Aniridia, Venice, Italy, 2014 (selected for oral presentation)

35. Fostad IG, Eidet JR, Ræder S, Messelt EB, Lagali NS, Dartt DA, Utheim TP. Identification of Objective Morphometric Markers of Xerostomia in the Oral Mucosal Epithelium of Dry Eye Disease Patients using In Vivo Confocal Microscopy, Digital Pathology Congress, London, 2014

36. Kahn A, Utheim, TP, Jackson C, Reppe S, Lyberg T, Eidet JR: Nucleus Morphometry in Cultured Epithelial Cells Correlates with Phenotype, Digital Pathology Congress, London, 2014

37. Chen X, Stojanovic A, Yang Z, Utheim TP. Corneal epithelial thickness profile changes after transepithelial surface ablation in treatment of myopia. XXXII European Society of Cataract & Refractive Surgeons, London, England, 2014

38. Salvanos P, Moe MC, Utheim TP, Bragadóttir R: Fundus autofluorescence in the evaluation of retinal detachment surgery. Rapid fire presentation, SOE2015, Vienna 6-9 June 2015 (selected for oral presentation)

39. Salvanos P, Stang Ø, Bragadóttir R, Utheim TP, Moe MC: Ophthalmological Complications after ball lightning injury. SOE2015, Vienna 6-9 June 2015

40. Salvanos P, Eide N, Moe MC, Utheim TP, Bragadóttir R: Retinal hemangioma in longstanding retinal detachment. SOE2015, Vienna 6-9 June 2015

41. Salvanos P, R. Øvergaard, Landsend E, Utheim TP, Moe MC, Bragadóttir R: Retinal Detachment from CSF leakage in Morning Glory Syndrome. SOE2015, Vienna 6-9 June 2015

42. Salvanos P, Moe MC, Utheim TP, Bragadottir R: Fundus autofluorescence in in optic disc melanocytoma SOE2015, Vienna 6-9 June 2015

43. Salvanos P, Ragnheidur B, Stene-Johansen I, Moe MC, Utheim TP: Long-term follow up of bomb explosion injury with fundus autofluorescence imaging SOE2015, Vienna 6-9 June 2015

44. Jackson C, Eidet JR, Eide L, Messelt E, Dartt DA, Griffith M, Bergersen LH, Utheim TP: Storage Temperature Affects Retention of Cell Integrity, Viability and Undifferentiated Cell Phenotype in Stored Cultured Epidermal Cell Sheets (oral presentation) - Norwegian Center of Stem Cell Research, Oslo, Norway, 2015

45. Salvanos P, Utheim TP Moe MC, Bragadottir R: Autofluorescence in Postoperative Evaluation of Amotio The Norwegian Ophthalmology Society, Oslo, Norway, 2014 (oral presentation)

46. Landsend ES, Utheim OA, Pedersen H, Baraas R, Tashbayev B, Lagali N, Dartt DA, Tor Paaske Utheim: Dry Eye Disease in a Norwegian-Danish Cohort of Congenital Aniridia, Gordon Conference, California, 2016

47. Landsend ES, Utheim OA, Adil MY, Pedersen H, Baraas R, Lagali N, Dartt DA, Utheim TP: Assessment of Meibography Images in a Norwegian-Danish Cohort of Congenital, Aniridia Gordon Conference, California, 2016

48. Nicolaissen BO, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Evaluation of the Dry Eye Ocular Surface Disease Index (OSDI) Questionnaire as a Predictive Test for Clinical Findings in Dry Eye Disease Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

49. Enayati S, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X Treatment Effects in Meibomian Gland Dysfunction in a Norwegian Cohort of Dry Eye Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

50. Borud I, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP: Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Tear Production, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

51. Salvanos P, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Interblink Interval, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

52. Salvanos P, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Ocular Surface Staining, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

53. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Correlation between Meibomian Gland Dysfunction and Age in a Norwegian Cohort of Dry Eye Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

54. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Tear Film Break-up Time as a Predictive Test Marker for Meibomian Gland Functionality and Dry Eye Severity Level in Patients with Meibomian Gland Dysfunction, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

55. Badian R, Borgersen N, Utheim TP, Lagali N: Dendritic cell analysis in wide-field images of the sub-basal nerve plexus by in vivo confocal microscopy, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

56. Landsend E, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP: Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Tear Film Break-up Time, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

57. Chen X, Stojanovic A, Simonsen D, Wang X, Liang J, Hu D and Utheim TP: Corneal Epithelial Thickness Profile Change After Corneal Collagen Cross-linking with and without Epithelial Removal in Treatment of Keratoconus, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016

58. Khan A, Utheim TP, Reppe S, Olstad OK, Fostad I, Eidet JR: Proteomic Characterization of Human Retinal Pigment Epithelium Cultured With Sericin, 16 th EURETINA Congress, Copenhagen, Denmark, 2016

59. Jensen JL, Utheim OA, Chen X, Thiede B, Aqrawi L, Rusthen S, Young A, Utheim TP, Galtung HK: Searching for Disease Biomarkers for Primary Sjögren’s Syndrome Based on Oral and Ocular Patient Examinations, Biomarkers and Targeted Therapeutics in Sjögren’s (BATTS) Conference, Oklahoma, US, September 19-22, 2016

60. Eidet JR, Tashbayev B, Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Gender Differences in Dry Eye Disease, TFOS, September 7-10, 2016, in Montpellier, France

61. Eidet JR, Tashbayev B, Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Air Pollution and Dry Eye Disease in Norway, TFOS, September 7-10, 2016, in Montpellier, France 

62. Lagali N, Wowra B, Utheim TP, Eden U, Wylegala E, Fagerholm P: Imaging limbal stem cell niche degradation and progression of aniridia related keratopathy in several patient cohorts, 3th European Aniridia Conference, Duisburg, Germany, 2016

63. Olstad OK, Raastad T, Reppe S, Gautvik VT, Kvernevik KJ, Utheim TP, Gautvik KM:

Postmenopausal osteoporosis is characterized by a distinct muscle transcription profile which can be markedly changed through heavy-load strength training; American Society for Bone and Mineral Research, Denver, September 8-11, 2017
64. Pedersen H, Hagen LA, Landsend ES, Gilson SJ, Gjelle J, Utheim OA, Utheim TP, Neitz M, Baraas R: Chromatic sensitivity in aniridia; 24th symposium of the International Colour Vision Society (ICVS), Erlangen, Germany, 2016

65. Pedersen H, Jon Gjelle VB,  Hagen LA, Landsend ES, Gilson S, Utheim OA, Utheim TP,  Baraas R: Refractive Errors and Ocular biometry in Aniridia. Refractive errors and ocular biometry in congential aniridia. The 16th International Myopia Conference, Birmingham, UK, September 2017

66. Dartt DA, Botten N, Hodges RP, Li D, Bair A, Shatos M, Utheim TP; Serhan CN: RvD2 Increases Goblet Cell cAMP and Intracellular [Ca2+] to Regulate Mucin Secretion anMaintain Ocular Surface Homeostasis in Both Health and Disease; Bioactive Lipids Meeting, Puerto Vallarta, Mexico, October 22 - 25, 2017

67. Bair JA, Olsen MV, Hodges RR,  Utheim TP, Serhan CN, Dartt DA: Comparison of signaling pathways used by the specialized pro-resolving mediators maresin1- and maresin-2 to regulate goblet cell function, The New York Academy of Sciences, New York, US, June 25 - June 26, 2018

68. Kosmina R, Utheim TP, Tønseth KA, Reppe S, Edin NF, Sandvik JA, Sehic A, Bergersen LH, Jackson CJ: Hypoxia Favors Maintenance of Undifferentiated Epidermal Cell Phenotype for Potential Treatment of Limbal Stem Cell Deficiency Following One-Week Storage/The Norwegian Society of Ophthalmology, Soria Moria, Oslo, Norway, 2017 (selected for oral presentration of abstract)

69. Landsend ES, Utheim TP: Analyses of the tear film in Aniridia/The Norwegian Society of Ophthalmology, Soria Moria, Oslo, Norway, 2017 (selected for oral presentration of abstract)

70. Utheim OA, Raeder S, Badian R, Chen X, Tashbayev B, Utheim TP:  Comparison of Ocular Surface Disease Index score and Clinical Dry Eye Disease Parameters in the Young (aged 0-19) and the Elderly (aged 80-99) (EVER 2018, accepted)

71. Botten N, Hodges RR, Li D, Bair JA, Shatos MA, Utheim TP, Serhan CN, Dartt DA:

Resolvin D2 Increases Mucin Secretion in Cultured Conjunctival Goblet Cells via the cAMP Signaling Pathway, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24 -28, 2018

72. Markus V. Olsen, Anne V. Lyngstadaas, Bair J, Hodges R, Utheim TP, Serhan CS, Dartt DA: Pro-resolving mediator maresin-1 regulates conjunctival goblet cell mucin secretion and tear film homeostasis, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018

73. Lyngstadaas AV, Olsen MV, Bair J, Hodges R, Utheim TP, Serhan CS, Dartt DA: The pro-resolving mediator Annexin A1 regulates MUC5AC secretion in cultured goblet cells suggesting a new use in inflammatory conjunctival diseases, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018

74. Lippestad M, Hodges R, Utheim TP, Serhan CS, Dartt DA: Signaling Pathways Used by Resolvin E1 to Increase Intracellular Ca2+ and Mucin Secretion in Conjunctival Goblet Cells, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018

75. Tashbayev BChen XUtheim ØARusthen SYoung AHerlofson BBHove LHSingh PBRykke MAqrawi LAUtheim TP, Garen T, Palm ØJensen JL: Primary Sjögren´s Syndrome and Non-Sjögren´s Sicca Syndrome Patients; unexpected differences in symptoms and findings of dry eye disease, dry mouth, and oral health related quality of life; 14th International Sjogren´s Syndrome Symposium, The Johns Hopkins University, Washington, DC

76. Utheim TP, Donnenfeld E, Holland E, Tauber J, Hamdani M, Shojaei A, Shire: Treatment of Dry Eye Disease with Lifitegrast Ophthalmic Solution 5.0%: Combined Efficacy and Safety from 5 Randomized Controlled Trials, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

77. Malmin A, Utheim TP, Meberg KO, Forsaa VA: Endophthalmitis after cataract surgery; single-center series over 14 years, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

78. Gautvik K, Günther GC, Yazdani M, Lindalen E, Valland H, Gautvik VT, Olstad OK, Holden M, Utheim TP, Reppe S: Distinct subsets of non-coding RNAs, including miRNAs, are associated with BMD in stressed and unstressed bone, The American Society of Bone and Mineral Research, Montréal, Québec, Canada, Sept 28 - Oct 1, 2018

79. Langeland Ø, Tashbayev B, Chen X, Utheim O, Young A, Herlofson BB, Rusthen S, Galtung H, Utheim TP, Jensen JL: Comparative Ocular and Oral Findings in Sicca Complex,

Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

80. Muhammed YA, Xiao J, Olafsson J, Chen X, Lagali N, Ræder S, Utheim OA, Dartt DA, Utheim TP: Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction (submitted): Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

81. Xiao J, Muhammed YA, Olafsson J, Chen X, Lagali N, Raeder S, Utheim OA, Dartt DA, Utheim TP: Development and Evaluation of A Novel Meiboscore for Meibography Analysis of Dry Eye Disease, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

82. Muhammed YA, Xiao J, Kinsang, Utheim TP, Chen DF: Elevated Intraocular Pressure Causes Retinal Ganglion Cell Dysfunction and Triggers Glaucomatous Neuropathy, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

83. Xiao J, Muhammed YA, Kinsang, Utheim TP, Chen DF: Evaluating the Retinal Function in Rhodopsin Knockout Mice with Quantification of Spatial Vision, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

84. Haughom B, Lerum S, Utheim TP, Kinge B: Referrals from General Practitioners and Optometrists; how do they compare, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

85. Khan A, Jackson CJ, Reppe S, Utheim TP, Olstad OK, Thiede B, Eidet JR: Sericin-Induced Melanogenesis in Cultured Retinal Pigment Epithelium is Associated with Elevated Levels of Hydrogen Peroxide, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway

86. Yang M, Lippestad M, Bair JA, Hodges RR, Utheim TP, Serhan CN, Dartt DA: Use BLT1 Receptor to Increase [Ca2+]i and Mucin Secretion in Health and Block LTB4-stimulated Increase in [Ca2+]i in Disease, The New York Academy of Sciences, New York, US, June 25 - June 26, 2018

87. Tellefsen S, Badian R, Stojanovic A, Utheim TP, Utheim OA, Tashbayev B, Raeder S, Chen X: Gender Differences in Symptoms and Signs of Dry Eye Disease in a Norwegian Cohort of Patients (EVER 2018, Nice, France) 

88. Gautvik, Kaare M; Günther, Clara-Cecilie; Yazdani, J.; Lindalen, Einar; Valland, Haldor; Gautvik, Vigdis Teig; Olstad, Ole Kristoffer; Holden, Marit; Utheim, Tor Paaske; Reppe, Sjur: Distinct subsets of non-coding RNAs, including miRNAs, are associated with BMD in stressed and unstressed bone. ASBMR Annual meeting 2018, September 29 – October 1, 2018, Montreal, Canada

89: Jensen JL, Chen X, Hynne H, Westgaard KL, Hove LH, Young A, Rykke M, Singh PB, Tashbayev B, Utheim OA, Utheim TP, Palm Ø, Amdal CD, Herlofson B: Sjögren’s versus radiated head-neck cancer patients: oral and ocular investigations, Oral Health Research Congress, Madrid, September 19-21, 2019 (submitted)

90: Hynne H, Westgaard KL, Herlofson BB, Amdal CD, Hove LH, Young A, Rykke M, Chen X, Tashbayev B, Singh PR, Utheim OA, Utheim TP, Jensen JL: Oral and Ocular Findings in Head and Neck Cancer Patients Post Radiation, Oral Health Research Congress, Madrid, September 19-21, 2019 (submitted)

91. Tashbayev B, Chen X, Utheum ØA, Rusthen S, Young A, Herlofson BB, Hove LH, Singh PB, Rykke M, Aqrawi LA, Utheim TP, Garen T, Palm Ø, Jensen JL: Non-Sjögren´s Syndrome Sicca Patients Have Lower General and Oral Health Related Quality of Life, NYSCO Conference, September 2 - 4, 2019

92.  Fjaervoll H, Fjaervoll K, Yang M, Bair JA, Magno MS, Utheim TP, Hodges R, Dartt DA: Identification of Purinergic 2 X Receptors (P2XR) in Conjunctival Goblet Cells, 31th Biennial Cornea Conference, Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, September 20 – 21, 2019

93.  Fjaervoll K, Fjaervoll H, Yang M, Bair JA, Magno MS, Utheim TP, Hodges R, Dartt DA: Identification of Purinergic Type 2 Y Receptors (P2YR) in Conjunctival Goblet Cells, 31th Biennial Cornea Conference, Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, September 20 – 21, 2019

94.  Bair J, Hodges R, Dartt DA, Nilsen O, Utheim TP: Culturing the Complete Conjunctival Epithelium - A Novel Method, 31th Biennial Cornea Conference, Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, September 20 – 21, 2019

95.  Dartt DA, Bair J, Olsen MV, Hodges RR, Utheim TP, Serhan C:  Maresin1- and Maresin-2 Use Distinct Signaling Pathways to Regulate Goblet Cell Function in the Eye. Bioactive lipids meeting, October 20-23, 2019

 

Publications in Peer-Reviewed Journals

 

2007

1. Ritland S, Utheim TP, Utheim OA Espeseth T, Lydersen S, Semb SO, Rootwelt H, Elsås T: Effects of APOE and CHRNA4 genotypes on retinal nerve fibre layer thickness at the optic disc and on risk for developing exfoliation syndrome. Acta Ophthalmol Scand. 2007 May; 85(3): 257-61

2. Utheim TP, Raeder S, Utheim OA, Cai Y, Roald B, Drolsum L, Lyberg T, Nicolaissen B: A novel method for preserving cultured limbal epithelial cells, Br J Ophthalmol. 2007 Jun; 91(6): 797-800

3. Raeder S, Utheim TP, Utheim OA, Cai Y, Roald B, Lyberg T, Kjeldsen-Kragh J, Ramstad H, Messelt E, Nicolaissen B: Effect of limbal explant orientation on the histology, phenotype, ultrastructure and barrier function of cultured limbal epithelial cells. Acta Ophthalmol Scand. 2007 Jun; 85(4): 377-86 (Cover page)

4. Raeder S, Utheim TP, Utheim OA Nicolaissen B, Roald B, Cai Y, Haug K, Kvalheim A, Messelt EB, Drolsum L, Reed JC, Lyberg T: The Effects of Organ Culture and Optisol-GS Storage on Structural Integrity, Phenotypes, and Apoptosis in Cultured Corneal Epithelium, Invest Ophthalmol Vis Sci. 2007 Des; 48(12): 5484-5493

 

2008

5. Utheim OA, Ritland JS, Utheim TP Espeseth T, Lydersen S, Rootwelt H, Semb SO, Elsås T: Apolipoprotein E-genotype and risk of development of cataract and age-related macular degeneration. Acta Ophthalmol Scand. 2008 Jun;86(4):401-3

 

2009

 

6. Utheim TP, Raeder S, Utheim OA de la Paz M, Roald B, Lyberg T: Sterility control and long-term eye-bank storage of cultured human limbal epithelial cells for transplantation. Br J Ophthalmol. 2009 Jul;93(7):980-3

7. Utheim TP, Raeder S, Olstad OK Utheim ØA, de La Paz M, Cheng R, Huynh TT, Messelt E, Roald B, Lyberg T: Comparison of histology, gene expression, and phenotype of cultured limbal epithelial cells of different limbal regional origin. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5165-72.

 

2010

8. Raeder S, Utheim TP, Messelt E, Lyberg T: The impact of de-epithelialization of the amniotic membrane matrix on morphology of cultured human limbal epithelial cells subject to eye bank storage" Cornea. 2010, Apr;29(4):439-45.

 

2012

9. Chen X. Stojanovic A, Zhou W, Utheim TP, Stojanovic F, Wang Q. Tansepithelial, topography-guided ablation in treatment of visually disturbing irregular astigmatism and/or scattering in Lasik-flap/interface complications. J Refract Surg. 2012 Feb;28(2):120-6  

10. Eidet JR, Utheim OA, Raeder S, Dartt DA, Lyberg T, Carreras E, Huynh TH, Messelt E, Louch WE, Roald B, Utheim TP. Effects of Serum-free Eye Banking on Morphology, Phenotype, and Viability of Ex Vivo Cultivated Human Conjunctival Epithelium Exp Eye Res. 2012 Jan; 94(1):109-16

11. Eidet JR, Fostad I, Shatos M, Utheim TP, Utheim OU, Raeder S, Dartt DA. Effect of Biopsy Location and Size on Proliferative Capacity of Ex Vivo Expanded Conjunctival Tissue Invest Ophthalmol Vis Sci. May 14;53(6):2897-903

12. Stojanovic A, Chen X , Zheng L, Xu Y, Stojanovic F, Utheim TP.  Late onset post-LASIK keratectasia with reversal and stabilization after use of Latanoprost and corneal collagen cross-linking. Eye Report, 2012 doi:104081

13. Chen X, Stojanovic A, Stojanovic F, Raeder S, Eidet JR, Oritsland H, Utheim TP. The effect of limbal marking prior to laser ablation on the magnitude of cyclotorsional error. J Refract Surg. 2012 May;28(5):358-62. 

14. Stojanovic A, Chen X, Nan J, Stojanovic F, Raeder S, Zhang T, Utheim TP: Safety and efficacy of epithelium-on corneal collagen cross-linking using a multifactorial approach to achieve proper stromal riboflavin saturation, J Ophthalmol, 2012; 2012:498435

15. Fostad I, Eidet JR, Shatos M, Utheim TP, Utheim OU, Raeder S, Dartt DA: Biopsy harvesting site and distance from the explant affect conjunctival epithelial phenotype ex vivo
Exp Eye Res. 2012 Nov; 104:15-25

 

2013

16. Engelsvold D, Utheim TP, Olstad OK, Pedro Gonzalez, Eidet JR, Lyberg T, Trøseid AM, Dartt DA, Raeder S: miRNA and mRNA Expression Profiling Identifies Members of the miR-200 Family as Potential Regulators of Epithelial-Mesenchymal Transition in Pterygium. Exp Eye Res. 2013 Oct;115:189-98

17. Pasovic L, Utheim TP, Lyberg T, Messelt EM, Chen DF, Aabel A, Chen X, Eidet JR: Optimization of Storage Temperature for Cultured ARPE-19 Cells.  J Ophthalmol. 2013;2013:216359. Epub 2013 Oct 22

18. Stojanovic A, Chen S, Chen X, Stojanovic F, Zhang J, Zheng L, Utheim TP: One-step transepithelial topography-guided ablation in the treatment of myopic astigmatism PLOS ONE. 2013 Jun 17;8(6)

19. Lagali N, Edén U, Utheim TP, Dellby, A, Riise R, Chen X, Fagerholm P:  In vivo morphology of the limbal Palisades of Vogt correlates with progressive stem cell deficiency in aniridia-related keratopathy. Invest Ophthalmol Vis Sci 2013 Aug 7;54(8):5333-42 

20. Liu Y; Yang X; Utheim TP; Guo C; Xiao M; Liu M; Ma: Correlation of Cytokine Levels and Microglial Cell Infiltration during Retinal Degeneration in RCS Rats, PLoS One. 2013 Dec 13;8(12):e82061

21. Utheim TP. Limbal epithelial cell therapy: past, present, and future, Methods Mol Biol. 2013;1014:3-43 (single author - 40 pages)

22. Parissi M, Karanis G, Randjelovic S, Germundsson J, Poletti E, Ruggeri A, Utheim TP, and Lagali N. Establishing a Standardized Baseline Human Corneal Subbasal Nerve Density for Clinical Investigations with Laser-scanning in Vivo Confocal Microscopy Invest Ophthalmol Vis Sci. 2013 Oct 29;54(10):7091-102

23. Utheim TP (2014). Why test BCG in Sjögren`s syndrome? In Faustman, D. (Ed.) “The Value of BCG and TNF in Autoimmunity”, London, Elsevier, pp. 105-125. (single author – 20 pages)

24. Islam R, Jackon C, Eidet JR, Messelt EB, Corraya RM, Lyberg T, Griffith M, Dartt DA, Utheim TP: Effect of Storage Temperature on Structure and Function of Cultured Human Oral Keratinocytes. PLoS One. 2015 Jun 8;10(6)

25. Utheim TP, Lyberg T, Raeder S. (2013) Culture of Limbal Epithelial Cells In Connon C. and Wright B. (Eds.). Methods Mol Biol. pp. 103-29 (27 pages)

 

2014

26. Eidet JR, Pasovic L, Corroya RM, Jackson C, Utheim TP: Objective Assessment of Changes in Cell Nucleus Morphology and Cell Distribution Following Induction of Apoptosis Diagn Pathol. 2014 May 12;9:92.

27. Pasovic L, Eidet JR, Lyberg T, Messelt EM, Aabel A, Utheim TP: Antioxidative Substances Improve the Viability of Stored ARPE-19 Cultures, Ophthalmol Ther. 2014 Mar 29.

28. Utheim TP, Hodges R.R. and Dartt D.A. (2014) The Eyelid. In: Linda M. McManus, Richard N. Mitchell, editors. Pathobiology of Human Disease. San Diego: Elsevier; 2014. Pp 2201-2215

29. Edén U, Lagali N, Dellby, A, Utheim TP, Riise R, Chen X, Fagerholm P:  

Cataract development in Norwegian patients with congenital aniridia. Acta Ophthalmol. 2014 Mar;92(2)

30. Stojanovic A, Zhou W, Utheim TP: Corneal Collagen Cross-Linking with and without Epithelial Removal – Contralateral Study with 0.5% Hypotonic Riboflavin Solution. Biomed Res Int. 2014;2014:619398. Epub 2014 Jun 22

31. Chen X, Stojanovic A, Hua Y, Eidet JR, Hu D, Wang J, Utheim TP: Repeatability and Reproducibility of Corneal Dynamic Scheimpflug Analyzer in Virgin and Post-PRK, PLoS One. 2014 Oct 10;9(10):e109577

32.  Jackson C, Aabel P, Eidet J, Messelt E, Lyberg T, von Unge M, Utheim TP: Xenobiotic Free Storage of Cultured Epidermal Cell Sheets for 14 Days – Effects of Temperature on Viability, Morphology, and Metabolic Status, PLoS One. 2014 Aug 29;9(8):e105808

33. Stojanovic A, Zhou, Utheim TP: Corneal collagen cross-linking with and without epithelial removal: A contralateral study with 0.5% hypotonic riboflavin solution. BioMed Research International. Vol. 2014. doi: 10.1155/2014/619398

 

2015

34. Bjoerkblom B, Eidet JR, Utheim TP, Ulltveit-Moe H, Raeder S: Xenobiotic- and Serum-Free Culture of Oral Mucosal Epithelial Cells on Contact Lenses for Ocular Surface Reconstruction Curr Eye Res. 2015 Aug 19:1-8.

35. Utheim TP: Transplantation of Cultured Oral Mucosal Epithelial Cells for Treating Limbal Stem Cell Deficiency - Current Status and Future Perspectives, Stem Cells. 2015 Jun;33(6):1685-95.

36. Utheim OA, Islam R, Lyberg T, Roald B, Eidet JR, De la Paz MF, Dartt DA, Raeder S, Utheim TP: Serum-Free and Xenobiotic-Free Preservation of Cultured Human Limbal Epithelial Cells PLoS One. 2015 Mar 3;10(3):e0118517.

37. Eidet, Jon Roger; Dartt, Darlene A.; Utheim, Tor P. Concise Review: Comparison of Culture Membranes Used for Tissue Engineered Conjunctival Epithelial Equivalents. Journal of Functional Biomaterials 2015, J Funct Biomater. 2015 Dec 11;6(4):1064-84

38. Hua Y, Stojanovic A, Utheim TP, Chen X, Ræder S, Huang J, Wang Q. Keratometric index obtained by Fourier-domain optical coherence tomography.PLoS One. 2015 Apr 17;10(4)

40. Salvanos P, Utheim TP, Moe MC, Bragadottir R, Eide N: Autofluorescence Pattern of Optic Disc Melanocytoma Acta Ophthalmol. 2015 Aug;93(5):476-80

41. Navaratnam J, Utheim TP, Shahdadfar A: Progress in Isolation and Culture Techniques in Tissue Engineering of Corneal Endothelium, J Funct Biomater. 2015 Sep 11;6(3):917-45.

42. Sehic A, Utheim ØA, Ommundsen K, Utheim TP. Pre-Clinical Cell-Based Therapy for Limbal Stem Cell Deficiency.J Funct Biomater. 2015 Aug 28;6(3):863-88.

43. Parissi M, Randjelovic S, Ruggeri A, Poletti E, Wihlmark TB, Utheim TP, and Lagali N. 

Corneal Nerve Regeneration After Collagen Cross-Linking Treatment of Keratoconus: A 5-Year Longitudinal Study. JAMA Ophthalmol. 2015 Nov 12:1-9

44. Utheim TP: Future Avenues of Research in Aniridia In Poli/Parekh/Ferrari/Teofili/Ponzin (Eds) "Recent Developments in Scientific and Clinical Research”, Springer, 2015

45. Chen, X, Stojanovic A, Hu D, Zhou Y, Wang J, Utheim TP: Postoperative Changes in Corneal Epithelial and Stromal Thickness Profiles after Photorefractive Keratectomy in Treatment of Myopia, J Refract Surg. 2015 Jul;31(7):446-53

46. Pasovic L, Eidet JR, Brusletto BS, Lyberg T, Utheim TP: Effect of Storage Temperature on Key Functions of Cultured Retinal Pigment Epithelial Cells, J Ophthalmol. 2015;2015:263756. 

47. Chen X, Stojanovic A, Eidet JR, Utheim TP: Treatment of keratoconus in thin corneas Eye and Vision 2015, Sept 2:15, 7 

48. Lagali N, Enea P, Dipika PV, McGhee C, Hamrah P, Kheirkhah A, Tavakoli M, Petropoulos I, Malik R, Utheim TP, Zhyvov A, Stachs O, Falke K, Peschel S, Guthoff R, Chao C, Golebiowski B, Stapleton F, Ruggeri A: Agreement in the expert clinical assessment of corneal subbasal nerve tortuosity. Invest Ophthalmol Vis Sci. 2015 Aug 1;56(9):5102-9

49. Eidet JR, Utheim OA, Islam R, Lyberg T, Messelt E, Dartt DA, Utheim TP: The Impact of Storage Temperature on the Morphology, Viability, Cell Number and Metabolism of Cultured Human Conjunctival Epithelium Curr Eye Res. 2015 Jan;40(1):30-9. 

 

2016

50. Sehic A, Khuu C, Utheim TP, Khan Q: MicroRNAs and Tooth Development;Model for Organogenesis? Microrna. 2016;5(2):132-139.

51. Fostad I, Utheim TP, Eidet JR, Raeder S, Lagali N, Messelt E, Dartt DA: Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility, PLoS One. 2016 May 5;11(5):e0155214.

52. Shatos MA, Hodges RR, Morinaga M, McNay DE, Islam R, Bhattacharya S, Turpie B,  Makarenkova HP, Masli S, Uthiem TP, Dartt DD: Alteration in Cellular Turnover and Progenitor Cell Population in Lacrimal Glands from Thrombospondin-1-/- Mice, a Model of Dry Eye, Exp Eye Res. 2016 Dec;153:27-41. 

53. Salvanos P, Moe MC, Utheim TP, Bragadottir R, Kerty E: Ultra-Widefield Fundus Imaging in the Diagnosis and Follow-up of Susac’s Syndrome, Retin Cases Brief Rep. 2016 Nov 8. 

54. Eidet JR, Reppe S, Pasovic L, Olstad OK, Lyberg T, Khan AZ, Fostad IG, Chen DF and Utheim TP: Silk-protein Sericin Induces Rapid Melanization of Cultured Human Retinal Pigment Epithelial Cells by Activating the NF-κB Pathway, Sci Rep. 2016 Mar 4;6:22671

55. Khan A, Utheim TP, Jackson C, Reppe S, Lyberg T and Eidet JR:  

Nucleus Morphometry in Cultured Epithelial Cells Correlates with Phenotype, Microsc Microanal. 2016 Jun;22(3):612-20. Neurochem Res. 2016 Jun;41(6):1229-36. 

56. Kolko M, Vosborg F, Henriksen UL, Hasan-Olive M, Holm Diget E, Vohra R, Gurubaran G, Gjedde A, Mariga SH, Skytt D, Utheim TP, Storm-Mathisen J, Bergersen LH: Lactate Transport and Receptor Actions in Retina: Potential Roles in Inner Retinal Function and Disease, Neurochem Res. 2016 Jun;41(6):1229-36.

57. Fostad IG, Eidet JR, Lagali NS, Dartt DA, Raeder S, Messelt EB, Utheim TP Identification of Objective Morphometric Markers of Xerostomia in the Oral Mucosal Epithelium With In Vivo Confocal Microscopy PLoS One. 2016 May 5;11(5):e0155214. 

58. Sehic A, Khan Q, Utheim OA, Utheim TP: The Role of Substrates for Cultured Oral Mucosal Cells in Treating Limbal Stem Cell Deficiency J Funct Biomater. 2016 Mar 1;7(1).

59. Chen X, Stojanovic A, Wang X, Jing L, Hu D, Utheim TP: Epithelial Thickness Profile Change after Combined Topography-guided Transepithelial Photorefractive Keratectomy and Corneal Crosslinking in Treatment of Keratoconus, J Refract Surg. 2016 Aug 1;32(9):626-34.

60. Chen X, Stojanovic A, Simonsen D, Wang X, Liang J, Hu D and Utheim TP: Corneal Epithelial Thickness Profile Change After Corneal Collagen Cross-linking with and without Epithelial Removal in Treatment of Keratoconus, J Refract Surg. 2016 Jun 1;32(6):418-25

61. Assessment Zhou W, Stojanovic A, Utheim TP Assessment of refractive astigmatism and simulated therapeutic refractive surgery strategies in coma-like-aberrations-dominant corneal optics. Eye Vis (Lond). 2016 May 12;3:13

62. Utheim TP, Salvanos P, Utheim OA, Ræder S, Pasovic L, Olstad OK, Fideliz de la Paz M, Sehic A: Transcriptome Analysis of Cultured Limbal Epithelial Cells on Intact Amniotic Membrane Following Hypothermic Storage in Optisol-GS, J Funct Biomater. 2016 Feb 18;7(1)

63. Khuu C, Utheim TP, Sehic A: The Three Paralogous MicroRNA Clusters in Development and Disease - miR-17-92, miR-106a-363, and miR-106b-25; Scientifica (Cairo). 2016; 2016:1379643

64. Utheim TP, Islam R, Fostad I, Eidet JR, Olstad OK, Sehic A, Messelt E, Dartt DA, Griffith M, Pasovic L, Eidet JR: Gene expression of cultured oral mucosal cells following xenobiotic-free storage for one week at 5ºC, 12ºC, and 37ºC, PLoS One. 2016 Mar 29;11(3)

65. He M, Storr-Paulsen T, Wang AL, Ghezzi CE, Wang S, Fullana M, Karamichos D, Utheim TP, Islam R, Griffith M, Islam MM, Hodges RR, Wnek GE, Kaplan DL, Dartt DA. Artificial Polymeric Scaffolds as Extracellular Matrix Substitutes for Autologous Conjunctival ex vivo Goblet Cell Expansion Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6134-6146.

66. Hua Y, Zhang X, Utheim TP; Huang J; Pan C; Tan W; Wang Q: Evaluation of Equivalent Keratometry Readings obtained by Pentacam HR (high resolution), PLoS One. 2016 Mar 7;11(3):e0150121. doi: 10.1371

67. Khuu C, Nirvani M, Utheim TP and Sehic A: MicroRNAs: Modulators of Tooth Development; Microrna. 2016;5(2):132-139. 

68. Sehic S, Tulek A, Khuu C, Nirvani M and Utheim TP: MicroRNAs in Human Dental Tissues; The Role in Development and Disease, Microrna. 2016;5(2):132-139.

69. Sehic A, Guo S, Kinsang C, Corraya M, Chen DF, Utheim TP: Electrical stimulation as a mean of improving vision. Am J Pathol. 2016 Nov;186(11):2783-2797.

70. Jackson C, Eidet JR, Reppe S, Aass HC, Tønseth KA, Roald B, Lyberg T, Utheim TP:

Effect of Storage Temperature on the Phenotype of Cultured Epidermal Cells Stored in Xenobiotic-Free Medium. Curr Eye Res. 2016 Jun;41(6):757-68

 

2017

71. Sehic A, Tulek A, Khuu C, Nirvani M, Sand LP, Utheim TP: Regulatory roles of microRNAs in human dental tissues.Gene. 2017 Jan 5;596:9-18. doi: 10.1016

72. Nirvani M, Khuu C, Utheim TP, Hollingen HS, Amundsen SF, Sehic A: Circadian Rhythms and Gene Expression During Mouse Molar Tooth Development, Acta Odontol Scand. 2017 Mar;75(2):144-153

73. Islam R, Eidet JR, Badian R, Lippestad M, Messelt E, Griffith M, Dartt DA, Utheim TP:

Tissue Harvesting Site and Culture Medium Affect Attachment, Growth and Phenotype of Ex Vivo Expanded Oral Mucosal Epithelial Cells, Sci Rep. 2017 Apr 6;7(1):674

74. Jackson C, Eidet JR, Reppe J, Eide L, Tønseth KA, Bergersen L, Dartt DA, Griffith M, and Utheim TP: Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Epidermal Cell Sheets, Sci Rep. 2017 Aug 15;7(1):8206

75. Aqrawi L, Galtung H, Vestad B, Øvstebø R, Thiede B, Rusthen S, Young Vik A, Guerreiro E, Utheim TP, Chen X, Utheim OA, Palm Ø, Jensen JL: Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis, Arthritis Res Ther. 2017 Jan 25;19(1):14.

76. Chen X, Stojanovic A, Xu Y, Zhou W, Raeder S, Enayati S, Utheim TP: Long-Term Results of Corneal Cross-Linking for Keratoconus Using Phototherapeutic Keratectomy For Epithelial Removal and Minimal Stromal Ablation, J Refract Surg. 2017 Jul 1;33(7):488-495

77. Jackson C, Tønseth A, Utheim TP: Cultured Epidermal Stem Cells in Regenerative Medicine, Stem Cell Research & Therapy, Stem Cell Res Ther. 2017 Jul 4;8

78. Lippestad M, Hodges R, Utheim TP, Serhan CS, and Dartt DA: Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells through Multiple Signaling Pathways, Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4530-4544.

79. Tashbayev B, Rusthen S, Chen X, Utheim O, Young A, Herlofson BB, Utheim TP, Jensen JL: Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren’s Syndrome, Sci Rep. 2017 Sep 7;7(1):10761.

80. Lagali N, Allgeier S, Guimarães P, Badian R, Ruggeri A, Köhler B, Utheim TP, Peebo B, Peterson M, Dahlin L, Rolandsson O: Decline in mosaic corneal nerve fiber density with duration of type 2 diabetes in an age-controlled cohort,Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6318-6327.

82. Chen X, Utheim OA, J, Adil MY, Stojanovic A, Tashbayev B, Jensen JL, Utheim TP: Evaluation of Dry Eye and Meibomian Gland Features in A Norwegian Cohort of Patients with Primary Sjögren´s Syndrome PLoS One. 2017 Sep 8;12(9):e0184284

83. Pasovic, L, Eidet JR, Olstad OK, Lyberg T, Chen DF, Utheim TP: Impact of Storage Temperature on the Expression of Cell Survival Genes in Cultured ARPE-19 Cells, Curr Eye Res. 2017 Jan;42(1):134-144

 

2018

84. Utheim TP, Utheim O, Salvanos P, Jackson C, Schrader S, Geerling G, Sehic A: Altered Versus Unaltered Amniotic Membrane as a Substrate for Limbal Epithelial Cells Stem Cells Transl Med. 2018 Mar 23. doi: 10.1002/sctm.17-0257

85. Tiedemann D, Mouhammad ZA, Utheim TP, Dartt DA, Heegaard S, Petrovski G, Kolko M. Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment J Glaucoma. 2018 Dec 24 (doi: 10.1097/IJG.0000000000001168)

86. Aabel P, Utheim TP, Olstad OK; Rask-Andersen H; Dilley RJ; von Unge M: Transcription and microRNA profiling of cultured human tympanic membrane epidermal keratinocytes. J Assoc Res Otolaryngol. 2018 Apr 5. doi: 10.1007/s10162-018-0660-1.

87. Guo G, Cho KS, Tchedre K, Ma J, Antolik C, Utheim TP, Huang XA, Chew J, Lashkari K, Malik MT, Chen DF: IGFBPL1 is an essential gatekeeper for IGF-1-induced axon growth signals, Sci Rep. 2018 Feb 1;8(1):2054. doi: 10.1038/s41598-018-20463-5.

88. Lagali N, Wowra B, Dobrowolski D, Fagerholm P, Wylegala E. Stage-related central corneal epithelial transformation in congenital aniridia-associated keratopathy.Ocul Surf. 2018 Jan;16(1):163-172. doi: 10.1016/j.jtos.2017.11.003. 

89. Nirvani M, Khuu C, Utheim TP, Sand LP, Sehic A. Circadian clock and oral cancer.Mol Clin Oncol. 2018 Feb;8(2):219-226. doi: 10.3892/mco.2017.1518. Epub 2017 Nov 27.

90. Khan AZ, Utheim TP, Reppe S, Sandvik L, Lyberg T, Roald B, Eidet JR: Optimization of Storage of Differentiated Human Retinal Pigment Epithelial Cells, Microsc Microanal. 2018 Apr;24(2):147-155.

91. Landsend ES, Pedersen H, Utheim OA, Hans Christian Aass, Tashbayev B, Lagali N, Dartt DA, Barass R, Utheim TP Tear Cytokine Profile in a Scandinavian Cohort of Congenital Aniridia (in press, IOVS)

92. Pedersen H, Hagen LA, Landsend ES, Gilson S, Gjelle JV, Utheim OA, Utheim TP, Neitz M, and Baraas R: Color Vision in Aniridia, Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2142-2152.

93. Pasovic L, Utheim TP, Reppe S, Khan A, Jackson CJ, Thiede B, Berg JP, Messelt E, Eidet JR: Improvement of Storage Medium for Cultured Human Retinal Pigment Epithelial Cells using Factorial Design, Sci Rep. 2018 Apr 9;8(1):5688. 

94. Lagali N, Allgeier S, Guimarães P, Badian R, Ruggeri A, Köhler B, Utheim TP, Peebo B, Peterson M, Dahlin L, Rolandsson O: Rapid automated generation and analysis of wide-area depth-corrected subbasal nerve plexus mosaics in a clinical setting, Sci Data. 2018 Apr 24;5:180075.

95. Lippestad M, Hodges R, Utheim TP, Serhan C, Dartt DA: Signaling Pathways Activated by Resolvin E1 to Stimulate Mucin Secretion and Increase Intracellular Ca2+ in Cultured Rat Conjunctival Goblet Cells, Exp Eye Res. 2018 Apr 25;173:64-72.

96. Utheim OA, Lyberg T, Eidet JR, Sehic A, Raeder S, Roald B, de la Paz M, Dartt DA, Utheim TP: Transportation of Cultured Limbal Epithelial Sheets for Worldwide Treatment of Limbal Stem Cell Deficiency, Sci Rep. 2018 Jul 12;8(1):10502.

97. Brejchovaa K, Trosana P, Studenyc P, Skalickaa P, Utheime TP, Bednarb J, Jirsovab K: Characterization and Comparison of Human Limbal Explant Cultures Grown Under Defined and Xeno-Free Conditions, Exp Eye Res. 2018 Nov;176:20-28

98. He M, Lippestad M, Li D, Hodges R, Utheim TP and Dartt DA:Activation of the EGF Receptor by Histamine Receptor Subtypes Stimulates Mucin Secretion in Conjunctival Goblet Cells, Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3543-3553

99. Yazdani M, Chen X, Tashbayev B, Ræder S, Utheim OA, Stojanovic S, Lagali N, Dartt DA, Utheim TP: Tear production levels and dry eye disease severity in a large Norwegian cohort, Curr Eye Res. 2018 Dec;43(12):1465-1470.

100. Lagali N, Badian RA, Liu X, Feldreich TR, Ärnlöv J, Utheim TP, Dahlin LB, and Rolandsson O: Dendritic cell maturation in the corneal epithelium with onset of type 2 diabetes is associated with tumor necrosis factor receptor superfamily member 9, Sci Rep. 2018 Sep 24;8(1):14248.

101. Reppe S, Jackson C, Ringstad H, Tønseth KA, Bakke H, Eidet JR, Utheim TP: High Throughput Screening of Additives using Factorial Design to Promote Survival of Stored Undifferentiated Epidermal Cells, Stem Cells Int. 2018 Nov 18;2018:6545876.

102. Aqrawi L, Chen X, Thiede B, Utheim OA, Palm Ø, Tashbayev B, Kaurstad M, Utheim TP, Jensen JL, Galtung H: Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome, PLoS One. 2018 Oct 12;13(10):e0205762. doi: 10.1371/journal.pone.0205762.

103. Tulek A, Saeed M, Mulic A, Stenhagen K, Utheim TP, Galtung HK, Khuu C, Nirvani M, Kristiansen MS og Sehic A: New Animal Model of Extrinsic Dental Erosion Erosive Effect on the Mouse Molar Teeth, Arch Oral Biol. 2018 Aug 24;96:137-145.

104. Landsend ES, Utheim OA, Pedersen HR, Lagali N, Baraas RC, Utheim TP: The Genetics of Aniridia - A Guide to the Ophthalmologists, Surv Ophthalmol. 2018 Jan - Feb;63(1):105-113. doi: 10.1016/

105. Kaye R, Botten N, Lippestad M, Li D, Hodges RR, Utheim TP, Serhan CN, Dartt DA.Resolvin D1, but not Resolvin E1, Transactivates the Epidermal Growth Factor Receptor to Increase Intracellular Calcium and Glycoconjugate Secretion in Rat and Human Conjunctival Goblet Cells, Exp Eye Res. Exp Eye Res. 2019 Mar;180:53-625. 

106. Thomseth V, Cejvanovic V, Jimenez-Solem E, Poulsen HR, Utheim TP, Andersen JT:Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: A Danish nationwide cohort study, Acta Ophthalmol. 2018 Nov 26. doi: 10.1111/aos.13980.

107. Adil MY, Xiao J, Olafsson J, Chen X, Lagali N, Ræder S, Utheim OA, Dartt DA, Utheim TP: Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction Am J Ophthalmol. 2018 Dec 19

108. Lång E, Polec A, Lång A, Blicher P, Rowe AD, Tønseth KA, Jackson C, Utheim TP, Eriksson JE, Bøe SO: Coordinated Collective Migration and Oriented Nuclear Partitioning in Sheets of Cultured Human Keratinocytes, Nature Communications, Nat Commun. 2018 Sep 10;9(1):3665.

 

2019

109. Skraastad BK, Knudsen C M, Jackson CJ, Utheim TP Pripp AH, Tønseth KA:Quality of life, patient satisfaction and cosmetic outcome after delayed breast reconstruction using DIEP flap; a 10 years’ follow-up survey, J Plast Surg Hand Surg. 2019 Jan 18:1-6.

110. Kaye R, Botten N, Lippestad M, Li D, Hodges RR, Utheim TP, Serhan CN, Dartt DA.Resolvin D1, but not Resolvin E1, Transactivates the Epidermal Growth Factor Receptor to Increase Intracellular Calcium and Glycoconjugate Secretion in Rat and Human Conjunctival Goblet Cells, Exp Eye Res. Exp Eye Res. 2019 Mar;180:53-62

111. Landsend ES, Pedersen HR, Utheim OA, MD, Xiao J, Muhammed A, Tashbayev B, Lagali N, Dartt DA, Baraas RC, Utheim TP: Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia. Br J Ophthalmol. 2019 Jan;103(1):119-124.

112. Stadnikova A, Trosan P, Skalicka P, Utheim TP, Jirsova K: Interleukin-13 maintains the stemness of conjunctival epithelial cell cultures prepared from human limbal explants, PLoS One. 2019 Feb 11;14(2):e0211861.

113. Nirvani M; Khuu C; Tulek A; Utheim TP; Sand LP; Snead ML; Sehic A: Transcriptomic Analysis of MicroRNA Expression in Enamel-Producing Cells, Gene. Gene. 2019 Mar 10;688:193-203

114. Yazdani M, Shahdadfar A, Jackson CJ, Utheim TP: Hyaluronan-Based Hydrogel Scaffolds for Limbal Stem Cell Transplantation: A Review. Cells. 2019 Mar 14;8(3). pii: E245. doi: 10.3390/cells8030245. Review.

115. Utheim OA, Pasovic L, Raeder S, Eidet JR, Fostad IG, Sehic A, Roald B, de la Paz MF, Lyberg T, Dartt DA, Utheim TP. Effects of explant size on epithelial outgrowth, thickness, stratification, ultrastructure and phenotype of cultured limbal epithelial cells.PLoS One. 2019 Mar 12;14(3)

116. Raheel TQ, Sørensen C, Jensen VJ, Dalen KT, Hassel B, Utheim TP, Tibor H, Fyhn M, Chaudhry F: Nanoscale regulation of GABA synapses and inhibitory plasticity by Slc38a1, a glutamine transporter, Cereb Cortex. 2019 May 3. pii: bhz055. doi: 10.1093/cercor/bhz055.

117. Pedersen H, Gilson JS, Neitz M, Landsend ES, Utheim OA, Utheim TP, Baraas R: The cone photoreceptor mosaic in aniridia: within-family phenotype-genotype discordance, Ophthalmol Retina. 2019 Jun;3(6):523-534. doi: 10.1016/j.oret.2019.01.020. Epub 2019 Feb 5.

118. Yazdani M, Chen X, Tashbayev B, Ræder S, Eidet JR, Utheim OA, Stojanovic S, Hua Y, Dartt DA, Utheim TP: Evaluation of the ocular surface disease index questionnaire as a predictive test for clinical findings in dry eye disease patients, Curr Eye Res. 2019 Sep;44(9):941-947. doi: 10.1080/02713683.2019.1604972. Epub 2019 Apr 29.

119. Botten N, Hodges R, Utheim TP, Serhan C, DA Dartt Resolvin D2 Elevates cAMP to Increase Intracellular [Ca2+] and Stimulate Secretion from Conjunctival Goblet Cells, FASEB J. 2019 Jul;33(7):8468-8478. doi: 10.1096/fj.201802467R. Epub 2019 Apr 23.

120. Chen X, Aqrawi L, Utheim TP, Tashbayev B, Utheim O, Reppe S, Hove LH, Palm Ø, Herlofson BB, Singh B, Galtung H, Jensen JL: Elevated cytokine levels in tears and saliva of patients with primary Sjögren’s syndrome correlate with clinical ocular and oral manifestations, Sci Rep. 2019 May 13;9(1):7319. doi: 10.1038/s41598-019-43714-5

121. Aqrawi LA, Galtung H, Guerreiro E, Øvstebø R, Thiede B, Utheim TP, Chen, Utheim OA, Palm Ø, Skarstein K, Jensen JL: Proteomic and histopathological characterisation of sicca subjects and primary Sjögren’s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers, Arthritis Res Ther. 2019 Jul 31;21(1):181. doi: 10.1186/s13075-019-1961-4.

122. Ræder S, Klyve P, Utheim TP. Dry eye disease – diagnostics and treatment,Tidsskr Nor Laegeforen. 2019 Aug 8;139(11). doi: 10.4045/tidsskr.18.0752. Print 2019 Aug 20. Norwegian.

123. Zhou W, Chen S, Chen X, Xu Y, Utheim TP, Stojanovic A: Transepithelial Topography-Guided Ablation Assisted by Epithelial Thickness mapping for Treatment of Regression After Myopic Refractive Surgery, J Refract Surg. 2019 Aug 1;35(8):525-533. doi: 10.3928/1081597X-20190730-01.

124. Yazdani M, Elgstøen KBP, Rootwelt H, Shahdadfar A, Utheim ØA, Utheim TP. Tear Metabolomics in dry eye disease: A rewiew: Int J Mol Sci. 2019 Aug 1;20(15). pii: E3755. doi: 10.3390/ijms20153755. Review.

125. Landsend ECS, Pedersen HR, Utheim ØA, Rueegg CS, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP. Characteristics and Utility of Fundus Autofluorescence in Congenital Aniridia Using Scanning Laser Ophthalmoscopy.Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4120-4128. doi: 10.1167/iovs.19-26994. 

126. Xiao J, Adil MY, Chen X, Utheim ØA, Ræder S, Tønseth KA, Lagali NS, Dartt DA, Utheim TP. Functional and Morphological Evaluation of Meibomian Glands in the Assessment of Meibomian Gland Dysfunction Subtype and Severity. Am J Ophthalmol. 2019 Sep 14. pii: S0002-9394(19)30462-3. doi: 10.1016/j.ajo.2019.09.005. 

127. Xiao J, Adil MY, Olafsson J, Chen X, Utheim ØA, Ræder S, Lagali NS, Dartt DA, Utheim TP.Diagnostic Test Efficacy of Meibomian Gland Morphology and Function.Sci Rep. 2019 Nov 22;9(1):17345. doi: 10.1038/s41598-019-54013-4.PMID: 31758085 Free PMC article.

128. Xiao J, Adil MY, Chang K, Yu Z, Yang L, Utheim TP, Chen DF, Cho KS.Visual Contrast Sensitivity Correlates to the Retinal Degeneration in Rhodopsin Knockout Mice. Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4196-4204. doi: 10.1167/iovs.19-26966. PMID: 31618423 Free PMC article.

129. Landsend ECS, Pedersen HR, Utheim ØA, Rueegg CS, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP.Characteristics and Utility of Fundus Autofluorescence in Congenital Aniridia Using Scanning Laser Ophthalmoscopy. Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4120-4128. doi: 10.1167/iovs.19-26994.PMID: 31574536 Free article.

 

2020

130. Olsen MV, Lyngstadaas AV, Zhou W, Stojanovic A, Utheim TP, Wang X, Badian RA, Chen X. Temporal redistribution of cap and residual stromal thickness following small-incision lenticule extraction. J Cataract Refract Surg. 2020 May 7.

131. Pedersen HR, Baraas RC, Landsend ECS, Utheim ØA, Utheim TP, Gilson SJ, Neitz M.PAX6 Genotypic and Retinal Phenotypic Characterization in Congenital Aniridia.Invest Ophthalmol Vis Sci. 2020 May 11;61(5):14. doi: 10.1167/iovs.61.5.14.PMID: 32396632

132. Yang M, Lippestad M, Hodges RR, Fjærvoll HK, Fjærvoll KA, Bair JA, Utheim TP, Serhan CN, Dartt DA. RvE1 uses the LTB4 receptor BLT1 to increase [Ca2+]i and stimulate mucin secretion in cultured rat and human conjunctival goblet cells. Ocul Surf. 2020 Apr 29:S1542-0124(20)30074-4. doi: 10.1016/j.jtos.2020.04.011. Online ahead of print.

133. Enayati S, Chang K, Achour H, Cho KS, Xu F, Guo S, Z Enayati K, Xie J, Zhao E, Turunen T, Sehic A, Lu L, Utheim TP, Chen DF. Electrical Stimulation Induces Retinal Müller Cell Proliferation and Their Progenitor Cell Potential.Cells. 2020 Mar 23;9(3):781. doi: 10.3390/cells9030781.PMID: 32210151 Free PMC article.

134. Tulek A, Mulic A, Refsholt Stenhagen K, Galtung HK, Saeed M, Utheim TP, Khuu C, Galteland P, Sehic A. Dental erosion in mice with impaired salivary gland function.Acta Odontol Scand. 2020 Mar 6:1-11. doi: 10.1080/00016357.2020.1734234. Online ahead of print. PMID: 32141357

135. Tashbayev B, Garen T, Palm Ø, Chen X, Herlofson BB, Young A, Hove LH, Rykke M, Singh PB, Aqrawi LA, Utheim ØA, Utheim TP, Jensen JL. Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study. Sci Rep. 2020 Feb 7;10(1):2063. doi: 10.1038/s41598-020-59078-0. PMID: 32034249 Free PMC article.

136. Utheim TP, Chen X, Fricke O, Bergersen LH, Lagali N. Microdot Accumulation in the Anterior Cornea with Aging - Quantitative Analysis with in Vivo Confocal Microscopy. Curr Eye Res. 2020 Feb 6:1-7. doi: 10.1080/02713683.2020.1725062. Online ahead of print.

PMID: 32026738

137. Gautvik KM, Günther CC, Prijatelj V, Medina-Gomez C, Shevroja E, Rad LH, Yazdani M, Lindalen E, Valland H, Gautvik VT, Olstad OK, Holden M, Rivadeneira F, Utheim TP, Reppe S. Distinct Subsets of Noncoding RNAs Are Strongly Associated With BMD and Fracture, Studied in Weight-Bearing and Non-Weight-Bearing Human Bone.J Bone Miner Res. 2020 Feb 3. doi: 10.1002/jbmr.3974. Online ahead of print. PMID: 32017184

138. Jackson CJ, Myklebust Ernø IT, Ringstad H, Tønseth KA, Dartt DA, Utheim TP.Simple limbal epithelial transplantation: Current status and future perspectives.Stem Cells Transl Med. 2020 Mar;9(3):316-327. doi: 10.1002/sctm.19-0203. Epub 2019 Dec 4.

139. Jirsova K, Seidler Stangova P, Palos M, Mahelkova G, Kalasova S, Rybickova I, Utheim TP, Vesela V. Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren's syndrome. PLoS One. 2020 Apr 21;15(4):e0231473. doi: 10.1371/journal.pone.0231473. eCollection 2020.

140. Yu H, Enayati S, Chang K, Cho K, Lee SW, Talib M, Zihlavnikova K, Xie J, Achour H, Fried SI, Utheim TP, Chen DF. Noninvasive Electrical Stimulation Improves Photoreceptor Survival and Retinal Function in Mice with Inherited Photoreceptor Degeneration.Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):5. doi: 10.1167/iovs.61.4.5.PMID: 32271885

141. Tashbayev B, Utheim TP, Utheim ØA, Ræder S, Jensen JL, Yazdani M, Lagali N, Vitelli V, Dartt DA, Chen X. Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease. Sci Rep. 2020 Mar 26;10(1):5542. doi: 10.1038/s41598-020-62583-x.PMID: 32218518 Free PMC article.

142. Lagali N, Wowra B, Fries FN, Latta L, Moslemani K, Utheim TP, Wylegala E, Seitz B, Käsmann-Kellner B. Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations. Ocul Surf. 2020 Jan;18(1):130-140. doi: 10.1016/j.jtos.2019.11.002. Epub 2019 Nov 14. PMID: 31734509 Free article.

143. Ringstad H, Reppe S, Schøyen TH, Tønseth KA, Utheim TP, Jackson CJ.Stem cell function is conserved during short-term storage of cultured epidermal cell sheets at 12°C. PLoS One. 2020 May 20;15(5):e0232270. 

144. Fineide F, Arita R, Utheim TP. The role of meibography in ocular surface diagnostics: A review. Ocul Surf. 2020 May 13:S1542-0124(20)30082-3

145. Olsen MV, Lyngstadaas AV, Bair JA, Hodges RR, Utheim TP, Serhan CN, Dartt DA.Maresin 1, a specialized proresolving mediator, stimulates intracellular [Ca2+ ] and secretion in conjunctival goblet cells. J Cell Physiol. 2020 Jun 8. doi: 10.1002/jcp.29846. 

146. Erickson S, Sullivan AG, Barabino S, Begovic E, Benitez-Del-Castillo JM, Bonini S, Borges JS, Brzheskiy V, Bulat N, Cerim A, Craig P, Cușnir V, Cușnir V Jr, Cușnir V, Doan S, Dülger E, Farrant S, Geerling G, Goldblum D, Golubev S, Gomes JAP, González-Méijome JM, Grupcheva CN, Gündüz ÖU, Horwath-Winter J, Källmark F, Karanadze N, Karcic HH, Karcic S, Kontadakis G, Messmer EM, Mrugacz M, Murphy C, O'Leary OE, Procopciuc V, Pult H, Raus P, Şahin A, Setälä N, Stanila A, Stanila DM, Utheim TP, Vehof J, Versura P, Villani E, Willcox MDP, Wolffsohn JS, Zagórski Z, Zoega GM, Sullivan DA; Moderators, Gomes JAP, Versura P, Willcox MDP. TFOS European ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases. Ocul Surf. 2020 Jun 3:S1542-0124(20)30084-7. doi: 10.1016/j.jtos.2020.05.006. Online ahead of print.

In addition, at present time (June 10, 2020) six papers in press, whereof one in Ocular Surface (impact factor 9,1) and one in Scientific Reports. 

References

 

Professor Morten Carstens Moe, Director of Research, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital (m.c.moe@medisin.uio.no)

Numerous other references and letters of recommendation (in total 23) can be given on request from all previous employers.

Emneord: regenerative medicine, stem cells, oral mucosa
Publisert 2. okt. 2018 13:11 - Sist endret 16. juni 2020 14:45